TSS:Rfhg 22090.1

Basic information about the TSS

---

TSS ID: rfhg_22090.1 Species: human Chr: chr1		Start: 244863882 End: 244863884 Strand: -
Source datasets
Protocol
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D2300859,EH38E1438748)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: AK307661:-108 GeneID: 3192 HGNC/MGI_ID: HGNC:5048 UniProt_ID: Nearer transcript ids and distances:

Gene_name: HNRNPU Gene_symbol: HNRNPU Gene_synonyms: FLJ30202 FLJ37978 SAF-A Gene_source: HGNC:5048

TATA-Box annotation

---

Distance to TSS:	642
Nearest PromoterID:	NM_004501
Entrez ID:	3192
Nearest Unigene:	Hs.106212
Nearest Refseq:	NM_004501
Nearest Ensembl:	ENSG00000153187
Gene Name:	HNRNPU
Gene Alias:	EIEE54|GRIP120|HNRNPU-AS1|HNRPU|SAF-A|SAFA|U21.1|hnRNP U|pp120
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.333333
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@HNRNPU p2@HNRNPU p3@HNRNPU p4@HNRNPU p5@HNRNPU p6@HNRNPU p7@HNRNPU p10@HNRNPU
Sample		p1@HNRNPU	p2@HNRNPU	p3@HNRNPU	p4@HNRNPU	p5@HNRNPU	p6@HNRNPU	p7@HNRNPU	p10@HNRNPU
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	177.66	286.75	53.57	10.13	3.70	18.31	4.48	1.36
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	174.60	319.87	55.44	9.51	5.46	15.58	6.27	2.02
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	168.60	310.96	54.78	11.19	4.24	17.17	5.02	3.86
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	133.89	294.82	44.70	9.15	3.33	16.22	3.12	1.66
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	152.53	314.50	48.14	9.22	4.05	18.45	2.70	2.92
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	157.76	307.00	54.27	9.30	4.26	16.67	4.65	1.55
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	262.77	323.34	71.47	16.56	3.49	20.05	10.46	4.14
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	220.66	335.96	64.67	14.78	5.57	16.71	4.84	1.45
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	189.99	295.36	66.25	14.96	2.56	17.74	4.70	0.64
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	210.98	288.65	53.33	15.65	6.96	13.33	1.74	1.16
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	172.20	235.67	49.32	13.74	5.66	12.53	3.64	2.02
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	200.02	251.25	47.57	11.79	3.25	15.45	1.22	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	42.55	34.66	19.02	2.10	1.13	1.13	0.64	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	39.09	26.91	18.04	1.35	0.30	0.30	0.45	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	39.52	28.32	15.81	1.54	0.88	0.44	0.88	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	36.97	24.90	18.86	1.01	1.26	0.00	1.26	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	40.62	24.68	19.00	0.87	0.87	0.22	0.87	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	41.34	31.64	18.98	0.42	0.84	0.00	1.69	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	38.92	29.86	13.86	0.53	0.53	0.53	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	40.77	24.82	13.84	0.90	1.05	0.60	0.30	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	45.71	30.74	21.38	1.60	0.67	0.40	1.07	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	41.77	30.21	23.99	1.21	0.69	0.52	0.17	0.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	38.78	29.86	20.29	0.78	0.39	0.39	0.65	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	35.91	33.25	18.20	0.49	0.73	0.73	0.73	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	40.76	30.96	19.61	0.52	0.00	1.29	0.52	1.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	43.36	36.08	17.72	0.63	0.63	0.95	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	46.15	39.56	20.88	0.55	2.20	2.75	0.00	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	48.80	42.67	17.92	0.94	0.47	0.47	2.59	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	45.23	31.01	19.54	0.81	0.32	0.16	0.32	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	41.26	35.83	14.30	1.63	0.36	0.72	0.36	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	33.29	34.33	18.63	0.84	0.84	1.05	0.63	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	34.39	37.51	16.80	0.39	0.98	0.98	0.00	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	40.94	32.50	16.67	1.48	1.48	1.27	0.84	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	41.73	34.64	19.46	1.32	0.49	0.82	1.15	1.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	35.53	28.24	16.83	1.12	0.37	1.68	0.56	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	36.60	33.92	18.20	0.77	0.77	0.38	0.96	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	43.74	34.54	17.58	1.43	1.23	2.04	1.02	1.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	32.44	25.99	16.52	1.21	0.20	0.60	1.01	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	42.41	34.84	20.80	1.35	1.62	0.00	0.81	1.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	42.49	38.41	18.96	0.72	0.24	0.72	0.72	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	34.82	30.11	14.12	0.47	0.71	0.94	1.18	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	47.72	32.35	19.18	1.32	0.59	0.59	1.02	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	36.91	35.01	16.03	0.63	0.63	1.05	1.27	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	42.13	32.17	16.78	1.05	1.22	0.87	0.52	1.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	38.35	32.73	16.86	2.01	0.40	0.40	1.00	1.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	41.88	34.90	19.31	0.93	1.63	0.47	2.09	1.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	31.43	33.11	18.47	0.96	1.20	0.00	0.48	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	41.13	35.17	19.67	0.60	1.79	0.89	0.89	1.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	37.10	34.71	20.11	1.44	1.68	0.48	0.24	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	38.42	32.96	16.58	1.62	0.20	0.61	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	52.88	41.81	20.91	1.43	0.20	1.02	0.61	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	44.70	40.25	19.79	1.78	1.11	0.67	2.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	293.84	111.94	83.95	0.00	41.98	0.00	55.97	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	40.10	41.16	22.00	2.84	2.13	1.06	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	33.80	46.39	20.21	0.66	0.33	0.00	0.33	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	53.69	43.62	20.13	1.68	2.52	1.68	15.10	3.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	38.12	29.85	19.29	0.92	1.38	0.00	2.30	2.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	38.89	35.33	15.23	0.65	0.65	0.32	0.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	34.04	35.33	11.56	0.00	2.89	0.32	0.64	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	31.75	28.92	11.00	1.26	1.26	0.31	1.89	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	29.61	36.66	19.74	2.12	1.41	0.00	0.71	2.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	26.92	38.69	19.63	0.00	1.12	0.00	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	22.29	15.13	5.57	0.80	2.39	0.80	7.17	4.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	25.14	26.84	11.55	1.02	1.36	0.68	1.36	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	40.29	29.89	13.32	1.30	0.32	0.00	0.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	41.89	24.14	21.65	1.77	0.71	0.00	1.77	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	242.46	64.66	80.82	0.00	0.00	0.00	0.00	48.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	173.74	94.77	102.67	7.90	23.69	0.00	23.69	15.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	30.71	27.30	17.06	0.49	0.49	0.00	0.49	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	36.20	26.28	20.33	0.99	0.50	0.00	0.50	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	39.41	20.17	15.48	0.00	0.47	0.00	0.00	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	24.84	21.20	8.28	0.99	0.66	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	24.44	17.63	11.45	0.31	0.62	0.31	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	27.52	20.18	13.15	1.22	0.92	0.00	0.31	0.00
Adipocyte - breast, donor1	11376-118A8	52.27	46.25	21.54	1.11	1.90	0.16	0.48	0.32
Adipocyte - breast, donor2	11327-117E4	50.69	61.76	17.97	1.76	1.60	0.32	0.96	1.28
Adipocyte - omental, donor1	11473-119C6	62.09	64.76	21.37	1.15	2.04	0.00	0.25	0.25
Adipocyte - omental, donor2	11474-119C7	20.93	43.35	11.21	0.75	0.00	0.75	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	21.77	51.91	12.39	2.68	0.00	0.33	0.00	0.33
Adipocyte - perirenal, donor1	11476-119C9	15.95	40.19	15.31	0.00	1.28	0.00	0.64	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	15.39	19.79	3.30	2.20	1.10	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	61.87	75.87	25.29	3.16	0.45	0.00	0.45	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	48.31	57.17	21.72	1.74	0.87	0.17	0.35	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	130.45	144.92	55.15	3.32	1.76	0.78	0.39	0.59
Adipocyte differentiation, day04, donor2	13022-139D7	81.33	109.90	46.84	2.57	0.51	0.51	0.51	1.03
Adipocyte differentiation, day04, donor3	13025-139E1	78.34	77.50	39.03	1.12	1.12	0.28	0.28	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	100.52	95.23	48.20	4.11	1.76	0.59	1.18	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	117.43	137.38	41.02	1.37	1.05	0.72	0.80	0.32
Adipocyte differentiation, day08, donor2	13023-139D8	83.92	97.15	34.86	2.58	1.29	0.65	0.65	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	67.18	73.58	24.53	1.07	0.53	0.00	1.60	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	72.34	92.92	35.06	3.34	0.56	2.23	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	41.17	70.70	18.72	0.83	0.42	0.00	0.00	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	51.49	81.63	26.87	1.00	0.50	0.75	0.25	0.75
Adipocyte differentiation, day12, donor3	13027-139E3	56.61	68.39	23.89	1.64	1.31	0.00	0.65	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	50.24	75.81	23.75	2.74	0.61	0.00	0.61	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	50.17	95.91	20.11	1.77	0.88	0.88	0.66	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	22.59	42.31	6.45	0.72	0.00	0.36	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	11.98	14.38	8.39	0.00	2.40	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	67.10	77.00	30.22	2.52	0.18	0.54	0.18	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	36.82	31.80	16.73	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	44.79	42.53	23.01	1.44	1.44	0.00	0.21	0.41
Anulus Pulposus Cell, donor1	11248-116E6	88.57	85.93	46.80	3.66	2.75	0.46	1.03	0.46
Anulus Pulposus Cell, donor2	11463-119B5	33.80	64.41	18.61	2.20	0.24	0.24	0.98	0.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	32.80	44.93	21.57	1.80	4.04	0.45	1.35	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	52.97	52.97	28.65	1.74	3.04	2.17	0.87	1.30
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	36.38	32.10	12.84	0.00	2.14	0.00	0.00	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	50.22	50.52	21.22	1.49	0.60	0.60	0.00	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	31.62	54.38	21.50	0.00	0.00	0.00	0.00	2.53
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	29.04	40.92	15.84	1.98	1.32	0.66	0.66	1.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	36.71	51.01	24.37	1.62	0.97	0.32	0.65	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	42.72	47.09	18.45	1.94	2.43	0.49	0.97	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	34.44	40.98	15.44	0.00	4.75	0.59	0.00	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	41.43	39.92	21.84	1.13	1.88	0.00	1.13	1.13
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	44.99	45.72	20.32	0.00	1.45	0.73	0.73	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	16.30	31.34	16.30	0.00	2.51	0.00	0.00	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	43.00	54.86	22.24	1.15	1.15	0.33	0.33	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	31.39	43.67	31.39	1.36	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	25.63	36.94	10.86	1.66	0.30	0.60	0.75	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	45.54	49.29	19.29	2.14	1.07	0.00	1.07	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	46.29	41.19	20.78	1.32	2.83	0.38	1.51	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	47.31	51.59	16.57	1.87	2.41	0.27	1.87	1.34
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	44.87	34.14	29.26	1.95	1.95	0.98	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	40.64	40.97	21.73	1.49	2.16	0.33	0.66	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	32.42	36.02	21.61	0.00	2.40	1.20	3.60	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	46.02	42.48	24.78	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	42.71	48.03	19.55	2.06	2.23	0.51	1.72	0.69
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	16.78	37.75	0.00	0.00	4.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	38.83	45.14	18.45	0.49	1.94	0.00	1.94	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	31.11	56.16	16.32	2.28	1.90	0.38	0.76	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	26.65	25.44	10.90	2.42	2.42	0.00	1.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	30.21	42.75	19.95	3.99	1.14	0.00	1.14	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	34.42	51.09	22.23	1.71	1.71	0.21	0.86	0.64
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	32.00	34.07	16.00	0.52	4.13	0.00	0.52	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	39.88	48.80	18.30	1.41	1.41	0.47	0.00	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	38.26	53.06	19.94	1.93	2.25	0.64	1.29	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	32.11	30.68	8.56	1.43	2.14	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	31.59	45.04	17.55	1.75	1.75	0.58	1.17	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	37.94	57.20	18.06	0.60	0.90	0.00	0.30	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	33.26	23.76	10.69	1.19	1.19	0.00	2.38	2.38
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	41.19	46.28	17.29	3.05	4.07	0.00	1.02	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	40.24	46.10	17.83	2.04	1.53	0.25	2.04	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	23.51	29.86	12.71	0.64	0.00	0.00	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	39.70	36.68	16.40	0.86	2.16	0.86	0.86	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	38.10	46.78	20.32	0.85	2.75	0.21	0.21	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	27.55	30.74	14.50	1.16	1.74	0.00	0.29	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	60.46	53.85	27.40	0.00	4.72	0.00	0.00	1.89
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	34.58	44.25	20.51	1.36	2.37	0.85	0.17	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	39.38	39.38	13.90	0.00	2.32	0.00	0.00	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	52.81	52.81	25.35	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	34.31	50.82	16.51	0.86	1.07	0.00	0.21	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	39.11	38.51	17.45	0.00	2.41	0.00	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	37.18	39.36	18.22	0.73	0.73	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	35.63	44.60	19.08	1.38	0.92	0.23	0.92	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	43.36	53.56	12.75	0.00	2.55	0.00	7.65	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	27.97	40.93	11.19	0.76	1.78	0.51	1.02	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	45.00	53.26	20.64	2.68	1.65	0.00	0.83	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	32.13	40.39	17.75	0.31	1.53	0.61	1.22	0.92
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	42.54	53.06	21.51	0.96	3.35	0.48	0.96	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	38.36	45.23	18.40	2.00	2.44	0.00	0.44	0.67
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	30.52	19.84	7.63	1.53	6.10	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	38.77	38.77	13.29	0.55	2.22	0.00	0.55	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	44.75	47.40	19.86	0.53	1.85	0.00	0.53	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	29.44	34.53	16.72	1.09	1.82	0.00	1.82	0.00
Astrocyte - cerebellum, donor1	11500-119F6	64.85	115.94	36.23	3.32	1.35	0.74	0.49	0.00
Astrocyte - cerebellum, donor2	11580-120F5	42.45	74.63	27.04	2.74	0.00	0.34	0.51	0.17
Astrocyte - cerebellum, donor3	11661-122F5	42.79	43.84	22.44	2.10	0.84	0.21	0.21	0.42
Astrocyte - cerebral cortex, donor1	11235-116D2	196.95	147.80	80.52	2.79	4.53	1.74	1.39	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	245.57	168.57	94.64	6.47	4.53	1.78	3.72	1.62
Astrocyte - cerebral cortex, donor3	11392-118C6	218.97	145.73	88.90	6.12	1.49	1.34	0.75	0.75
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	400.14	259.53	182.58	11.24	4.82	2.64	3.78	2.41
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	505.39	322.73	204.96	13.41	2.88	5.01	1.88	1.63
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	469.07	301.33	185.49	15.02	2.73	4.10	2.05	2.50
Basophils, donor1	12241-129G9	81.34	42.63	28.77	0.26	0.52	1.05	0.26	0.26
Basophils, donor2	12242-129H1	169.21	56.64	46.18	0.00	0.36	3.25	0.00	0.36
Basophils, donor3	12243-129H2	139.35	78.06	54.24	1.03	0.73	0.59	0.29	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	23.93	42.69	14.66	1.29	0.22	0.43	0.43	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	5.03	19.66	4.11	0.91	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	28.69	71.74	14.35	7.17	7.17	0.00	7.17	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	26.36	59.00	18.83	3.77	0.00	1.26	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	40.55	65.09	21.63	2.70	0.21	0.42	0.00	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	18.65	39.84	13.82	2.76	0.46	0.23	0.23	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	41.39	64.42	24.29	2.34	0.90	0.36	2.52	0.54
Burkitt's lymphoma cell line:DAUDI	10422-106C8	282.99	167.16	110.99	3.92	2.99	3.61	0.93	0.82
Burkitt's lymphoma cell line:RAJI	10476-106I8	241.06	166.06	104.34	5.36	3.73	9.32	1.86	1.40
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	225.12	133.67	63.00	3.20	1.60	7.04	0.32	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	361.97	144.79	41.37	0.00	0.00	10.34	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	126.24	63.68	40.58	1.69	2.82	0.00	1.13	0.00
CD14+ Monocytes, donor2	11305-117B9	178.36	93.17	60.88	3.90	1.30	1.30	3.16	0.74
CD14+ Monocytes, donor3	11381-118B4	165.97	87.60	55.76	1.76	1.10	1.32	1.54	1.32
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	127.09	100.48	75.57	2.26	1.42	0.00	0.85	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	127.37	101.21	60.65	1.14	0.38	0.00	0.76	1.14
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	138.07	126.57	71.01	1.97	0.66	0.66	0.33	0.66
CD14+ monocytes - mock treated, donor1	11863-125A9	160.74	116.07	55.51	2.17	1.45	0.72	0.87	1.88
CD14+ monocytes - mock treated, donor2	11873-125C1	90.52	123.71	41.94	0.91	0.91	0.30	0.00	0.91
CD14+ monocytes - mock treated, donor3	11883-125D2	109.21	134.08	50.22	3.08	0.71	0.71	0.47	0.47
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	121.87	143.79	42.85	1.84	2.34	0.33	2.34	0.84
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	85.29	157.60	34.78	1.38	1.10	0.28	2.21	0.83
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	79.83	185.45	31.24	1.49	1.98	0.74	1.24	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	111.41	216.36	38.96	3.72	2.55	0.59	0.78	0.78
CD14+ monocytes - treated with BCG, donor2	11870-125B7	80.12	119.47	26.71	1.60	2.14	0.18	1.25	1.42
CD14+ monocytes - treated with BCG, donor3	11880-125C8	69.42	176.28	28.73	1.96	0.22	1.09	1.09	1.52
CD14+ monocytes - treated with Candida, donor1	11868-125B5	95.99	254.03	36.52	2.81	1.17	0.47	1.87	1.17
CD14+ monocytes - treated with Candida, donor2	11878-125C6	75.51	259.26	30.63	3.70	0.53	0.53	2.64	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	82.09	309.51	35.50	2.22	1.11	0.00	2.22	2.22
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	131.64	129.86	44.77	2.83	2.68	0.45	1.49	1.64
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	85.21	118.93	35.12	1.20	1.00	1.00	0.80	1.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	75.58	144.49	28.52	1.04	0.00	0.42	1.04	1.25
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	121.26	242.97	45.07	2.97	3.43	0.00	2.06	1.60
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	73.97	215.57	30.31	2.49	0.23	0.68	1.58	1.81
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	65.47	250.96	31.43	2.18	0.87	0.44	2.62	2.62
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	132.61	141.22	41.96	2.69	1.61	0.27	1.88	1.34
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	113.40	103.45	40.82	1.57	0.87	0.52	1.74	0.52
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	93.00	172.12	39.14	2.95	0.00	1.68	0.42	2.10
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	110.78	212.00	40.97	4.59	2.02	0.18	6.98	2.39
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	84.90	259.62	36.99	3.52	0.00	0.00	1.76	1.41
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	76.78	273.76	36.85	3.95	0.44	0.00	1.32	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	92.42	206.11	36.79	1.74	3.49	0.70	2.09	2.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	74.34	154.62	32.71	2.60	0.37	1.49	5.20	2.97
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	86.65	190.11	35.13	0.86	0.00	1.08	1.08	0.86
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	115.48	221.53	39.31	2.05	1.23	0.41	2.46	2.05
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	67.92	236.43	32.22	2.09	0.23	0.93	0.70	0.70
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	57.07	197.66	27.38	1.86	0.23	0.46	0.46	0.70
CD14+CD16+ Monocytes, donor1	11789-124B7	64.95	38.36	34.44	0.65	0.44	0.00	0.44	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	93.78	42.04	43.89	0.23	1.15	0.00	0.92	0.92
CD14+CD16+ Monocytes, donor3	11912-125G4	69.53	45.06	29.24	0.22	0.43	0.65	0.65	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	140.62	66.03	54.50	0.93	0.93	0.47	1.40	0.47
CD14+CD16- Monocytes, donor2	11799-124C8	127.84	59.03	52.74	1.57	1.05	0.17	0.35	0.87
CD14+CD16- Monocytes, donor3	11910-125G2	180.60	93.42	79.60	1.56	0.45	0.22	0.67	0.89
CD14-CD16+ Monocytes, donor1	11790-124B8	106.41	30.11	48.74	1.53	0.26	1.28	0.26	0.51
CD14-CD16+ Monocytes, donor2	11800-124C9	97.93	37.98	41.06	0.88	0.88	0.44	0.88	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	78.32	45.69	40.42	0.63	0.63	0.21	1.26	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	180.88	52.84	52.84	0.00	2.03	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	207.46	58.31	85.43	0.68	0.68	0.68	0.68	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	191.59	61.10	82.85	4.14	3.11	1.04	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	202.02	59.70	73.56	1.07	2.67	1.60	3.20	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	242.30	82.55	104.53	3.22	1.07	2.14	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	221.81	51.24	73.00	2.81	0.70	1.40	0.70	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	179.62	67.45	83.14	5.49	0.78	0.00	1.57	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	214.88	60.64	89.64	5.27	2.64	1.32	1.32	0.00
CD19+ B Cells, donor1	11544-120B5	235.89	57.53	78.08	0.00	1.64	0.00	6.58	0.82
CD19+ B Cells, donor2	11624-122B4	187.16	43.53	72.54	2.90	2.18	1.45	0.73	1.45
CD19+ B Cells, donor3	11705-123B4	209.50	46.95	67.65	2.52	0.50	1.51	1.01	1.51
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	251.32	276.38	114.75	7.68	14.55	3.23	4.85	1.21
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	178.17	200.94	74.31	4.79	15.18	4.79	0.80	0.40
CD34+ Progenitors, donor1	11545-120B6	91.37	38.15	17.07	1.00	0.00	2.01	1.00	0.00
CD34+ Progenitors, donor2	11625-122B5	81.46	74.72	34.27	2.25	0.00	6.74	0.56	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	208.54	173.97	80.04	2.25	1.13	5.64	0.38	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	241.72	167.31	65.16	3.16	2.93	6.09	0.45	0.45
CD4+ T Cells, donor1	11225-116C1	537.01	99.62	142.82	2.86	3.21	5.36	3.21	1.07
CD4+ T Cells, donor2	11306-117C1	413.96	87.57	110.84	1.22	11.63	3.67	6.74	2.45
CD4+ T Cells, donor3	11382-118B5	313.23	64.05	84.79	3.35	3.05	4.27	4.57	3.66
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	122.00	44.16	66.11	1.79	0.00	1.02	0.77	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	141.27	54.58	80.63	1.12	4.04	1.35	0.67	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	133.38	48.87	79.05	1.15	0.57	0.86	0.29	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	233.25	44.09	67.80	0.95	1.90	3.79	1.42	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	247.22	37.22	81.47	1.40	2.11	5.62	2.11	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	227.44	32.96	105.48	0.00	3.30	3.30	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	137.00	44.94	53.47	0.72	1.01	1.73	0.43	0.72
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	146.25	52.19	77.27	2.37	1.86	0.34	0.85	0.68
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	123.16	54.49	70.12	1.77	1.45	0.32	1.13	1.77
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	149.28	36.31	60.52	0.45	1.34	2.24	0.90	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	143.60	36.34	63.59	0.35	0.00	2.10	1.05	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	167.63	62.48	76.12	0.88	0.44	1.76	1.76	1.76
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	137.03	61.56	64.51	1.69	1.26	1.69	2.53	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	141.70	61.71	70.43	2.70	2.70	0.42	1.87	1.25
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	132.98	62.15	58.47	1.34	4.34	0.33	1.67	1.34
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	270.57	49.49	78.86	1.90	1.90	4.89	1.36	0.82
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	250.29	50.38	80.93	1.61	0.54	6.43	3.22	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	247.47	69.94	111.18	1.79	3.59	5.38	1.79	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	193.96	67.50	80.48	2.97	0.56	2.41	1.67	0.56
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	133.44	45.06	70.40	1.30	1.95	1.08	0.65	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	134.08	49.60	72.92	2.10	1.47	0.84	1.26	0.42
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	192.13	27.30	57.64	2.02	0.51	3.03	1.01	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	191.93	42.46	62.39	0.87	1.73	2.60	0.43	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	201.35	55.78	81.06	1.31	1.31	4.36	1.74	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	250.40	64.33	109.37	0.99	1.48	5.44	1.48	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	151.40	63.70	97.86	0.92	0.92	1.85	0.00	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	206.58	36.29	106.08	1.40	0.00	1.40	1.40	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	154.25	78.37	92.77	0.55	0.55	8.58	0.83	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	192.39	97.67	125.15	1.96	0.25	9.32	0.74	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	223.30	80.08	104.72	0.00	0.00	3.08	1.54	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	268.59	68.76	122.12	1.43	1.43	6.45	0.72	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	232.68	78.94	145.42	1.38	1.38	6.92	1.38	0.00
CD8+ T Cells, donor1	11226-116C2	348.68	53.04	93.31	1.31	2.29	5.89	0.98	0.98
CD8+ T Cells, donor2	11307-117C2	316.86	41.30	77.34	2.63	5.63	3.00	6.01	2.63
CD8+ T Cells, donor3	11383-118B6	383.03	58.32	106.80	1.77	3.28	5.30	5.55	2.78
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	81.43	173.42	65.61	3.21	3.67	1.38	4.13	1.84
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	82.44	168.47	71.65	2.88	3.35	2.16	3.35	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	93.02	143.91	68.12	4.92	3.01	1.64	3.28	1.09
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	94.87	150.71	73.25	6.60	3.30	1.20	2.40	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	75.83	142.79	67.20	3.12	2.40	0.96	2.64	0.96
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	81.40	158.94	63.21	3.64	2.50	1.14	1.59	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	90.61	165.57	62.36	3.69	2.82	1.74	3.04	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	75.54	190.82	69.22	7.37	3.16	1.84	2.11	1.32
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	95.45	183.39	68.01	5.63	1.64	1.41	3.28	0.47
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	98.71	164.83	57.05	7.55	4.23	1.81	4.53	0.91
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	108.65	158.62	65.07	4.94	3.78	2.32	2.03	2.91
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	87.39	163.06	67.14	5.06	4.00	1.33	1.60	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	60.41	200.93	42.02	3.50	2.19	0.44	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	71.50	183.54	36.43	4.10	3.19	0.00	0.91	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	37.29	170.80	29.83	2.24	2.98	0.00	0.00	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	83.56	180.08	68.07	5.04	1.80	0.72	1.08	1.08
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	88.33	155.08	69.34	5.47	2.01	1.44	1.44	1.15
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	87.91	141.65	54.45	4.24	1.65	2.83	1.18	0.94
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	111.23	208.21	65.92	4.44	4.12	1.27	5.39	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	118.72	220.52	77.51	4.92	6.15	2.46	2.46	0.92
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	98.10	185.62	67.00	2.89	2.89	0.96	1.92	1.28
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	89.88	149.54	61.19	3.44	4.59	1.91	1.15	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	81.97	168.68	53.20	6.31	3.15	1.18	3.94	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	67.32	152.04	50.68	3.78	1.51	3.78	3.03	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	85.92	301.11	73.87	8.03	1.61	0.80	0.80	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	101.42	293.06	80.43	6.29	2.10	2.10	2.10	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	84.15	257.45	61.11	16.03	1.00	1.00	5.01	1.00
Cardiac Myocyte, donor1	11525-119I4	106.01	116.98	43.87	10.97	0.00	1.83	0.00	1.83
Cardiac Myocyte, donor2	11605-120I3	76.09	88.44	41.01	4.94	0.99	0.99	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	80.61	66.40	33.04	1.89	0.84	0.42	0.21	0.32
Chondrocyte - de diff, donor1	11261-116G1	51.31	73.49	26.00	2.08	0.35	1.39	1.04	0.00
Chondrocyte - de diff, donor2	11338-117F6	37.67	41.22	20.26	1.42	0.71	0.00	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	78.51	63.37	32.65	2.62	2.73	0.68	0.68	0.57
Chondrocyte - re diff, donor2	11339-117F7	111.01	64.46	47.45	1.79	0.00	1.79	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	51.36	23.05	20.62	0.00	0.81	0.00	1.21	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	201.74	128.64	89.40	5.05	1.95	2.64	1.03	0.92
Ciliary Epithelial Cells, donor2	11323-117D9	123.77	82.30	51.73	4.28	2.78	2.14	1.07	1.71
Ciliary Epithelial Cells, donor3	11399-118D4	138.50	114.69	59.47	3.10	1.33	1.95	1.06	0.44
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	159.10	107.38	69.51	7.06	0.37	1.38	0.28	0.18
Corneal Epithelial Cells, donor1	11526-119I5	23.06	37.99	13.17	0.88	0.22	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	28.44	42.09	17.06	3.41	2.28	0.00	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	54.96	59.56	24.03	2.30	1.53	0.26	0.00	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	81.39	95.59	44.91	1.65	0.66	0.00	0.17	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	80.74	93.99	33.12	1.58	1.58	0.00	1.58	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	55.21	79.37	31.06	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	67.71	70.52	34.02	1.62	0.97	0.22	0.65	0.54
Dendritic Cells - plasmacytoid, donor1	11228-116C4	270.24	52.27	62.86	1.37	3.07	1.37	0.34	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	238.30	53.54	42.44	1.31	0.00	1.31	0.65	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	139.86	45.49	48.39	0.48	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	84.22	74.55	38.52	2.17	0.50	1.33	0.17	0.50
Endothelial Cells - Aortic, donor1	11263-116G3	46.94	57.50	24.64	1.17	0.00	1.17	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	79.47	106.33	30.26	1.98	0.28	0.28	1.13	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	55.44	61.73	21.23	1.57	0.39	0.00	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	74.17	72.72	25.02	1.45	1.16	0.29	0.29	1.16
Endothelial Cells - Artery, donor2	11341-117F9	141.64	125.40	47.76	3.06	2.59	2.35	3.76	0.71
Endothelial Cells - Artery, donor3	11413-118E9	99.58	98.87	42.60	1.05	0.53	0.53	0.53	0.53
Endothelial Cells - Lymphatic, donor1	11236-116D3	79.57	88.00	36.57	0.66	0.89	0.00	0.22	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	81.24	93.41	29.82	3.04	0.00	0.30	0.00	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	86.54	110.51	37.49	1.41	0.00	0.56	0.28	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	41.90	65.67	25.26	1.78	1.19	0.89	0.00	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	48.94	42.69	17.70	0.52	0.00	0.52	0.00	1.04
Endothelial Cells - Microvascular, donor3	11414-118F1	64.80	44.24	27.51	2.13	0.28	0.43	1.13	0.57
Endothelial Cells - Thoracic, donor1	11266-116G6	102.43	162.05	52.42	3.20	2.40	5.60	0.40	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	74.95	64.99	21.49	1.57	3.14	0.00	0.00	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	236.57	212.83	92.32	4.72	2.61	4.22	0.99	0.62
Endothelial Cells - Umbilical vein, donor2	11324-117E1	165.77	158.38	68.00	5.00	0.22	1.30	1.30	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	222.27	233.02	86.83	5.86	0.98	1.59	1.59	0.24
Endothelial Cells - Vein, donor1	11267-116G7	47.78	56.88	19.34	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	60.07	66.36	20.96	0.70	0.00	1.40	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	86.67	65.63	26.69	1.41	0.16	0.63	0.94	0.31
Eosinophils, donor1	12244-129H3	320.19	45.74	30.49	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	221.14	67.66	120.47	4.95	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	181.91	124.84	142.67	0.00	3.57	0.00	0.00	7.13
Esophageal Epithelial Cells, donor1	11507-119G4	29.32	46.67	14.66	0.73	0.49	0.24	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	8.32	22.88	10.40	0.00	2.08	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	65.08	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	62.40	40.23	19.70	1.23	3.28	0.00	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	15.88	24.09	6.68	0.44	0.33	0.33	0.77	0.22
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	28.17	34.56	13.33	1.41	0.65	0.76	0.65	0.54
Fibroblast - Aortic Adventitial, donor1	11245-116E3	100.78	88.05	42.69	2.30	2.30	1.21	0.97	0.97
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	120.09	143.02	50.63	3.41	0.41	1.50	0.27	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	72.67	73.51	26.26	1.90	2.00	0.00	1.16	0.53
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	108.03	166.26	76.15	4.74	0.26	1.32	0.53	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	117.93	99.66	44.85	2.99	0.66	2.33	1.99	1.66
Fibroblast - Cardiac, donor1	11268-116G8	54.44	48.54	23.13	0.45	0.00	1.81	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	65.94	52.30	21.22	1.52	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	59.62	41.32	28.39	1.10	1.10	0.16	1.10	0.16
Fibroblast - Cardiac, donor4	11452-119A3	146.10	138.82	57.29	2.12	0.30	2.42	0.00	0.30
Fibroblast - Cardiac, donor5	11456-119A7	71.83	85.91	39.34	3.30	0.76	0.63	1.02	0.25
Fibroblast - Cardiac, donor6	11460-119B2	77.01	109.00	40.78	3.34	0.45	0.76	0.91	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	47.83	75.03	29.21	1.34	0.67	0.13	0.00	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	78.95	67.73	42.71	1.73	2.16	0.43	0.43	0.86
Fibroblast - Choroid Plexus, donor3	11653-122E6	74.70	95.21	41.01	2.93	11.72	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	68.27	117.63	45.67	3.46	0.46	1.61	0.23	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	83.95	86.33	52.58	1.87	0.00	0.17	0.51	0.00
Fibroblast - Dermal, donor1	11269-116G9	55.88	80.53	33.57	2.58	0.70	3.52	0.47	0.47
Fibroblast - Dermal, donor2	11346-117G5	65.56	123.58	34.90	3.30	0.00	2.83	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	64.67	70.60	39.53	3.14	1.69	1.21	0.97	0.60
Fibroblast - Dermal, donor4	11450-119A1	106.38	162.90	64.10	5.88	0.79	3.17	1.13	0.23
Fibroblast - Dermal, donor5	11454-119A5	115.66	192.42	74.67	6.11	2.62	3.14	0.17	0.17
Fibroblast - Dermal, donor6	11458-119A9	121.49	215.54	81.05	7.63	1.79	3.57	0.97	0.16
Fibroblast - Gingival, donor1	11237-116D4	91.20	101.62	53.10	3.12	1.25	0.62	0.42	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	86.46	107.16	50.30	4.98	0.26	0.26	0.26	1.57
Fibroblast - Gingival, donor2	11318-117D4	152.61	142.19	69.71	4.48	4.88	0.92	2.37	0.66
Fibroblast - Gingival, donor3	11394-118C8	109.93	125.02	60.91	4.83	0.39	0.39	0.48	0.39
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	91.42	95.58	39.48	1.04	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	74.71	67.13	29.95	3.70	1.41	0.00	1.41	0.70
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	128.30	146.54	54.41	4.68	1.25	0.16	1.56	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	97.63	134.15	47.87	4.33	2.03	0.95	1.08	0.54
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	114.69	148.56	58.23	4.59	0.00	0.00	0.00	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	84.82	111.44	39.92	3.51	0.73	0.88	1.02	0.44
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	104.45	121.63	52.09	5.32	1.23	1.36	0.27	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	133.94	172.22	54.85	5.16	1.54	2.30	0.55	0.99
Fibroblast - Gingival, donor9 (control)	11927-125I1	80.85	81.15	35.07	2.05	0.29	0.73	0.73	0.59
Fibroblast - Lung, donor1	11270-116H1	24.47	48.94	16.31	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	119.37	146.23	53.72	1.49	0.00	2.98	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	129.58	98.34	59.30	3.59	2.32	0.84	0.63	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	38.32	132.45	34.15	2.50	0.00	0.83	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	11.19	47.55	19.58	1.40	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	15.11	20.43	5.88	1.12	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	118.14	155.49	56.43	4.47	0.00	0.81	0.41	0.00
Fibroblast - Mammary, donor2	11620-122A9	47.93	35.95	23.97	7.99	0.00	0.00	3.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	77.43	59.56	17.87	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	160.22	171.28	71.77	4.66	4.46	1.16	1.16	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	258.92	247.39	120.74	9.56	2.28	2.12	0.91	1.21
Fibroblast - Periodontal Ligament, donor3	11395-118C9	154.22	184.51	76.50	4.90	0.31	2.75	0.00	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	80.52	108.38	43.12	2.29	0.38	0.76	1.14	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	78.84	70.74	29.97	2.16	1.89	0.27	1.62	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	71.44	79.44	30.04	2.32	0.35	0.12	0.58	0.23
Fibroblast - Pulmonary Artery, donor1	11250-116E8	102.80	91.19	34.82	2.32	3.09	1.55	1.22	0.66
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	76.60	111.75	33.93	2.24	0.20	1.02	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	57.47	55.46	38.76	4.01	1.34	0.67	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	60.49	58.12	33.61	3.16	3.16	0.00	0.79	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	180.19	297.47	131.77	9.53	2.38	0.79	0.99	0.79
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	57.37	77.09	31.08	0.53	0.71	0.18	1.24	0.53
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	76.86	102.88	31.34	1.38	0.39	0.20	0.59	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	131.77	173.59	77.32	3.61	0.60	0.90	0.90	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	74.27	118.42	41.89	2.91	0.43	0.65	0.65	0.32
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	114.14	185.50	89.84	6.07	1.77	0.25	0.51	0.25
Fibroblast - skin normal, donor1	11553-120C5	57.43	81.71	28.39	1.31	0.49	0.16	0.49	0.66
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	217.15	237.00	99.65	7.22	1.40	1.20	1.00	0.60
Fibroblast - skin normal, donor2	11561-120D4	59.27	99.76	34.26	3.52	0.60	0.30	0.30	0.40
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	173.48	308.89	155.35	9.97	0.60	0.60	1.21	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	91.88	85.75	40.01	2.07	1.82	0.25	0.25	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	61.20	103.77	33.16	2.22	0.85	0.34	0.68	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	105.10	172.43	73.90	3.28	0.66	0.33	0.66	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	54.97	93.21	33.66	2.56	0.64	0.32	0.64	0.21
Fibroblast - skin walker warburg, donor1	11554-120C6	95.81	112.85	42.34	2.36	0.67	0.34	0.67	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	27.13	26.19	12.39	0.78	0.63	0.16	0.94	0.47
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	509.68	576.15	243.76	0.00	22.16	22.16	22.16	22.16
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	82.80	50.55	33.99	3.49	0.00	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	56.51	80.26	22.71	1.91	0.87	0.00	0.87	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	68.18	84.58	30.71	2.86	1.04	0.52	0.26	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	65.67	95.82	26.83	2.56	0.77	0.51	0.26	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	142.39	171.48	62.01	6.89	8.42	13.78	0.77	1.53
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	185.04	180.57	76.57	5.74	5.74	20.42	3.19	4.47
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	170.87	216.80	56.48	6.85	18.54	24.25	5.99	1.43
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	142.29	142.57	69.77	11.03	8.27	3.58	6.07	3.86
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	144.99	118.96	57.54	10.50	6.85	4.11	2.74	4.34
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	143.45	171.78	53.30	5.55	4.76	13.47	3.76	3.17
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	128.20	133.49	72.16	8.99	6.87	1.32	5.55	5.82
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	156.88	112.52	55.77	7.18	2.61	2.61	1.30	2.94
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	130.90	203.42	36.26	7.08	15.04	23.00	7.08	3.54
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	279.11	237.14	116.45	10.18	4.10	7.63	3.53	0.99
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	255.27	204.05	109.47	10.71	2.46	5.42	2.96	0.86
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	265.67	227.79	87.30	12.63	5.91	6.72	3.22	2.15
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	189.80	141.86	86.97	5.08	1.61	1.49	1.24	0.74
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	211.10	197.81	100.64	8.86	3.32	4.15	3.05	1.66
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	171.38	166.51	70.34	8.95	3.25	3.86	2.24	1.42
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	139.42	103.82	62.29	5.93	4.79	2.05	1.37	1.14
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	154.09	145.49	76.23	7.85	1.99	1.62	2.49	1.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	136.61	157.16	67.98	9.18	2.19	1.31	1.31	0.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	151.58	98.99	54.96	6.21	1.77	0.00	0.89	1.77
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	226.04	156.41	95.22	6.99	2.54	1.91	3.50	1.27
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	139.86	137.63	67.03	7.82	2.01	0.67	1.34	0.67
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	205.06	113.72	76.62	5.04	2.22	0.81	1.21	1.61
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	241.06	152.85	107.21	6.28	3.73	1.87	2.54	1.02
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	250.50	201.91	82.91	6.12	1.42	1.51	0.80	1.24
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	219.14	119.77	85.22	4.37	1.04	0.94	0.52	0.62
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	162.07	120.06	65.24	3.76	0.68	1.02	0.68	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	211.68	127.14	97.60	5.86	1.66	0.22	2.32	0.66
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	212.32	135.03	75.21	3.49	2.25	1.41	1.08	1.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	174.17	144.97	67.99	5.72	0.61	1.02	0.41	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	146.48	86.24	56.12	4.95	3.09	0.21	0.62	0.62
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	201.42	118.87	98.81	5.76	2.88	0.46	1.61	0.92
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	169.60	94.56	68.71	4.50	2.50	0.83	1.67	0.83
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	129.39	76.93	57.53	3.53	1.32	0.00	1.10	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	177.48	89.05	75.27	3.81	1.84	0.49	1.84	0.37
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	176.84	103.58	62.08	6.32	2.27	0.97	1.46	0.65
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	127.64	93.65	60.62	5.77	2.25	0.00	1.92	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	166.01	88.78	72.49	3.60	1.52	0.19	1.42	0.76
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	132.87	76.24	58.37	3.16	2.21	0.16	0.79	0.79
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	155.39	77.85	48.05	4.26	2.74	0.61	1.82	1.22
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	159.63	86.66	69.20	3.35	2.30	0.10	1.05	0.73
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	114.39	64.11	46.33	3.29	2.85	0.22	1.10	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	130.17	85.57	51.90	1.96	3.37	0.00	1.68	1.68
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	130.73	95.27	64.44	3.43	0.83	0.28	1.48	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	106.16	87.17	30.22	5.35	1.60	0.27	1.34	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	145.20	97.16	54.01	2.75	1.53	0.77	1.38	0.92
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	133.42	86.79	50.91	1.94	1.30	0.65	2.07	1.04
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	113.04	79.15	36.59	3.52	1.36	0.27	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	137.89	88.12	49.22	2.77	2.40	0.37	1.84	1.11
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	123.25	76.76	46.06	2.85	2.41	0.22	1.32	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	282.65	191.41	85.29	3.97	0.00	0.00	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	118.98	82.45	43.53	1.85	2.51	0.00	0.92	0.53
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	100.07	69.00	42.77	2.22	1.61	0.20	0.81	1.01
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	233.83	139.03	86.16	4.07	0.25	0.25	1.02	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	210.61	319.89	100.33	11.35	2.19	19.31	2.99	1.99
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	282.58	234.66	118.48	13.10	3.54	8.32	2.62	1.69
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	444.76	305.44	162.03	13.91	2.66	12.89	3.68	1.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	167.42	183.69	61.96	3.13	4.07	17.52	1.56	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	161.06	172.64	66.68	3.39	3.67	18.37	1.41	3.11
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	222.76	234.75	75.64	8.30	4.15	20.29	3.69	2.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	215.31	272.23	84.14	4.95	0.00	9.90	9.90	7.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	251.04	320.66	89.35	10.44	6.58	13.15	5.42	2.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	224.63	293.62	64.18	8.02	22.46	12.84	9.63	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	189.53	217.35	73.03	8.69	6.96	6.96	6.96	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	219.05	264.94	76.81	5.86	6.51	5.53	4.88	3.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	228.14	281.26	74.95	10.30	4.94	12.35	8.24	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	203.27	193.27	63.31	0.00	16.66	0.00	53.32	13.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	200.23	230.43	80.54	7.55	4.75	3.92	3.08	1.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	219.64	246.44	76.81	8.17	8.17	5.23	4.90	2.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	173.64	166.09	68.78	3.36	8.39	3.36	17.62	9.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	249.37	242.69	96.69	9.22	5.09	4.45	3.82	3.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	219.08	236.40	77.78	9.17	7.81	7.13	3.06	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	123.20	123.20	68.91	0.00	6.26	2.09	4.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	231.37	214.19	92.20	7.45	3.44	1.72	5.73	1.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	160.72	158.35	60.38	6.51	5.62	0.59	1.78	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	140.61	138.92	42.35	6.78	11.86	3.39	10.16	6.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	232.78	230.30	89.05	9.11	6.21	4.14	6.21	3.73
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	284.21	254.29	100.11	9.90	8.05	6.44	2.53	2.76
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	105.37	105.37	31.61	5.27	0.00	0.00	10.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	186.44	176.06	63.81	5.38	5.00	2.69	3.84	1.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	156.79	147.34	68.45	5.22	3.91	1.30	2.93	1.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	85.61	84.94	36.79	1.34	2.01	1.34	1.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	196.87	174.14	83.22	6.16	5.01	2.70	4.24	3.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	289.28	192.74	77.03	8.90	6.16	6.50	1.71	2.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	89.45	131.69	72.06	9.94	4.97	0.00	27.33	7.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	139.67	121.74	58.51	5.66	4.72	0.47	1.42	2.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	163.55	115.87	62.76	7.24	4.83	1.21	5.43	3.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	152.09	92.07	56.46	6.61	3.05	1.02	0.51	2.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	191.04	134.01	78.97	5.98	4.39	1.60	3.59	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	140.11	114.46	69.56	4.93	1.97	1.97	3.45	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	88.53	81.45	41.32	4.72	8.26	1.18	3.54	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	140.61	114.94	64.18	2.92	7.58	0.00	1.17	1.75
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	117.18	121.57	46.96	3.51	3.07	0.88	2.19	1.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	128.85	128.85	47.47	6.78	3.39	1.70	1.70	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	117.59	114.61	40.59	4.18	4.18	1.19	2.98	1.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	143.63	113.55	64.54	6.31	2.91	0.97	6.31	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	36.52	46.79	18.26	0.00	1.14	0.00	0.00	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	68.61	57.38	31.19	2.49	8.73	0.42	2.91	2.49
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	35.98	34.86	15.74	0.00	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	50.43	84.36	32.35	2.85	0.95	0.00	0.63	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	33.00	43.45	16.71	0.84	1.67	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	137.74	246.01	47.23	8.59	9.05	2.55	3.25	2.20
Hep-2 cells mock treated, biol_rep2	11899-125E9	134.53	330.85	53.51	8.10	5.06	2.03	2.19	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	138.09	350.13	56.42	7.28	4.32	2.28	4.32	1.59
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	139.70	253.82	52.47	6.45	8.74	1.53	4.70	1.75
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	140.12	309.26	50.93	6.88	3.87	3.22	1.72	1.29
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	128.09	325.29	54.90	8.40	4.52	0.86	1.94	1.72
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	121.30	208.85	41.60	4.86	5.11	1.74	3.86	1.49
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	109.28	246.52	37.74	6.52	3.26	2.40	2.57	1.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	118.54	286.41	41.97	4.81	3.52	1.28	3.20	0.64
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	35.82	71.63	22.94	1.12	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	52.37	51.94	20.34	2.16	0.87	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	66.10	124.26	15.86	0.00	10.58	5.29	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	56.79	79.01	22.22	0.71	0.35	0.71	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	26.88	58.12	13.80	1.45	0.00	0.00	1.45	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	81.30	101.41	31.12	1.57	3.15	1.22	2.27	0.35
Hepatocyte, donor1	11523-119I2	77.48	78.69	39.95	3.63	2.42	1.21	0.00	2.42
Hepatocyte, donor2	11603-120I1	106.66	145.44	42.02	3.23	1.08	2.15	5.39	7.54
Hepatocyte, donor3	11684-122I1	67.49	121.48	37.43	2.45	1.84	1.84	0.61	1.84
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	290.45	107.04	69.18	3.26	4.57	0.65	1.96	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	193.31	160.27	75.33	3.15	1.92	1.92	1.57	0.87
Iris Pigment Epithelial Cells, donor1	11530-119I9	80.68	78.35	35.54	2.88	0.55	0.55	0.27	0.69
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	76.41	73.23	50.94	3.18	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	40.05	73.43	33.38	6.68	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	54.17	54.17	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	87.22	73.37	42.92	5.54	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	60.06	30.03	35.04	0.00	0.00	0.00	0.00	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	83.08	213.63	59.34	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	97.39	92.26	48.70	2.56	0.00	0.00	2.56	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	45.71	13.71	45.71	9.14	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	121.82	107.21	64.97	6.50	1.62	1.62	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	130.05	116.71	41.68	1.67	1.67	3.33	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	79.87	47.20	32.68	0.00	0.00	3.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	112.49	93.97	59.56	5.29	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	134.15	95.34	53.21	6.65	1.11	1.11	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	99.53	83.81	52.38	10.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	145.50	97.00	62.99	4.41	0.63	3.15	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	116.00	77.33	60.32	4.64	0.00	3.09	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	102.44	29.27	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	124.69	93.03	65.90	3.88	0.00	1.29	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	133.62	78.89	57.96	8.05	0.00	3.22	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	59.74	35.84	71.69	11.95	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	123.05	93.71	68.45	4.07	0.00	0.81	0.81	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	115.45	73.89	49.54	2.10	0.00	0.84	0.42	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	43.12	57.49	0.00	0.00	0.00	0.00	14.37
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	131.00	81.98	69.92	7.23	0.00	2.41	0.00	1.61
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	97.87	80.33	63.71	3.69	0.00	0.92	0.92	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	45.24	15.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	118.48	70.33	61.84	2.83	0.47	1.89	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	86.16	69.84	43.54	4.53	0.00	2.72	2.72	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	44.23	14.74	44.23	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	107.61	82.86	76.40	4.30	1.08	0.00	0.00	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	127.05	104.18	67.33	3.81	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	65.72	49.29	65.72	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	102.03	89.91	65.68	3.19	0.00	0.00	0.00	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	102.07	87.49	47.39	1.82	0.00	1.82	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	47.41	94.83	63.22	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	132.82	64.27	73.55	1.43	0.00	2.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	73.00	132.73	79.64	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	62.55	83.39	62.55	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	138.90	74.70	76.86	5.86	0.93	1.23	0.00	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	122.92	96.58	87.80	7.02	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	119.44	59.72	69.15	0.00	0.00	3.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	132.82	79.97	78.58	7.65	0.00	0.70	0.00	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	39.84	24.34	26.56	4.43	2.21	2.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	74.57	55.11	45.39	6.48	0.00	3.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	68.88	42.72	38.36	0.87	0.00	0.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	62.99	38.25	33.75	4.50	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	41.81	24.39	27.88	3.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	52.27	25.60	32.00	1.07	0.00	0.00	1.07	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	77.58	59.57	29.09	1.39	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	105.44	102.59	45.59	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	75.47	48.78	46.02	2.76	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	30.25	24.20	21.18	0.00	0.00	3.03	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	31.04	18.63	55.88	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	34.89	28.55	30.66	0.00	0.00	0.00	1.06	0.00
Keratinocyte - epidermal, donor1	11272-116H3	74.66	113.42	31.91	3.35	2.45	0.73	0.49	0.41
Keratinocyte - epidermal, donor2	11349-117G8	24.01	42.75	5.86	0.00	0.00	0.59	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	108.57	99.29	46.57	2.18	1.89	1.14	1.42	1.42
Keratinocyte - oral, donor1	11251-116E9	147.35	127.03	70.04	6.58	2.72	1.14	1.14	1.02
Keratocytes, donor1	11527-119I6	58.45	88.02	30.94	2.41	0.69	1.72	0.00	0.00
Keratocytes, donor2	11607-120I5	39.84	75.00	22.26	2.34	1.17	0.00	0.00	1.17
Keratocytes, donor3	11688-122I5	68.96	88.92	42.29	2.96	0.59	0.99	0.79	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	138.47	171.44	46.16	6.59	0.00	0.00	2.20	0.00
Lens Epithelial Cells, donor1	11529-119I8	91.69	77.67	42.07	1.08	1.08	1.08	4.31	0.00
Lens Epithelial Cells, donor2	11609-120I7	115.10	86.04	57.78	2.54	0.69	0.35	0.46	0.46
Lens Epithelial Cells, donor3	11690-122I7	96.87	104.84	43.29	2.22	0.50	0.61	0.30	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	73.87	60.83	29.41	1.42	1.19	0.47	0.47	0.83
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	55.26	36.56	16.47	0.84	1.95	0.84	1.40	0.84
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	94.76	62.49	33.06	1.42	6.77	1.57	2.83	1.73
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	46.78	48.93	23.12	2.15	1.61	1.08	1.08	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	51.37	29.94	18.59	0.95	0.95	0.32	0.63	0.95
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	45.61	34.18	18.11	1.08	2.16	0.65	0.65	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	67.71	67.30	19.70	1.23	2.05	0.82	2.46	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	31.35	21.24	12.14	0.25	1.52	0.25	0.51	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	61.65	41.66	22.10	1.13	2.11	0.42	1.41	0.42
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	47.07	58.54	22.15	0.79	1.58	0.40	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	50.99	46.14	16.48	1.74	1.94	0.19	1.36	0.78
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	28.88	18.33	8.89	0.19	2.04	0.19	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	48.08	43.90	18.47	0.70	3.83	0.35	2.44	0.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	47.23	37.69	17.17	0.95	1.67	0.00	0.48	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	45.87	35.16	18.40	1.24	2.47	0.27	2.20	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	48.35	61.90	18.48	1.54	0.62	0.00	0.92	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	24.00	20.58	6.86	0.94	1.25	0.62	0.94	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	64.23	45.75	27.08	1.10	2.38	0.55	1.10	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	59.57	52.66	18.43	0.66	1.65	0.99	0.99	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	26.65	17.28	8.20	0.00	0.88	0.00	0.59	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	40.08	30.12	17.43	0.25	1.74	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	48.50	68.38	18.91	1.45	1.94	0.97	0.48	1.45
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	43.63	42.01	14.00	0.27	1.62	0.81	0.54	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	67.82	40.12	24.52	0.45	2.72	0.76	0.61	0.91
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	35.77	51.84	16.59	1.04	0.00	0.00	1.56	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	41.88	49.83	16.33	0.63	2.09	1.47	1.88	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	52.78	35.64	19.85	0.75	2.56	0.75	1.35	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	41.27	66.04	14.45	1.38	0.00	1.38	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	37.25	42.71	14.11	0.19	0.19	0.75	0.94	0.75
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	47.18	27.89	15.69	1.38	1.38	0.32	1.06	0.85
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	50.88	72.20	19.87	0.97	1.45	0.48	2.42	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	36.39	37.38	13.23	0.99	0.66	0.66	1.32	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	49.31	31.96	20.07	0.99	2.11	0.00	1.86	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	83.30	72.93	32.58	1.85	0.00	1.11	1.11	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	36.32	36.32	5.68	0.49	1.98	0.49	0.25	1.24
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	38.77	25.85	15.95	1.24	0.55	0.27	0.96	0.41
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	52.75	63.04	21.55	0.64	2.57	0.64	0.96	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	55.08	59.65	20.69	1.22	1.52	0.00	0.61	0.91
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	76.56	54.17	31.07	1.12	2.52	0.42	1.96	0.84
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	58.67	59.73	20.62	0.71	4.27	0.36	1.07	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	17.94	31.03	3.39	0.00	0.97	0.48	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	36.26	22.25	13.85	1.09	1.24	0.00	0.78	0.47
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	47.27	51.93	18.26	2.86	1.43	1.43	1.07	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	38.22	38.55	15.35	0.65	1.96	0.98	0.65	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	31.08	19.07	11.77	0.24	1.88	0.00	1.18	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	75.61	86.75	24.63	2.60	1.24	0.74	0.74	0.37
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	27.15	17.42	9.22	0.51	0.77	0.00	0.51	0.77
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	48.63	39.38	25.36	0.30	0.90	0.30	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	43.05	40.79	20.39	0.00	2.27	0.00	2.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	50.63	76.71	21.48	3.07	0.77	0.00	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	31.92	73.48	16.33	2.97	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	40.20	80.82	22.43	2.12	1.27	0.00	0.42	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	37.28	64.71	16.88	0.70	1.41	0.00	2.11	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	39.23	72.85	18.68	0.93	0.00	0.93	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	42.25	67.50	18.03	2.06	3.09	0.00	2.06	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	32.12	51.15	8.33	1.19	1.19	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	44.79	58.13	14.70	1.36	0.45	0.68	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	57.00	119.82	27.92	1.74	3.49	0.29	1.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	68.43	118.40	22.96	4.05	4.50	0.00	0.90	1.35
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	62.87	89.29	23.44	2.03	0.27	0.27	0.41	0.27
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	39.54	77.54	11.81	1.54	2.05	0.00	1.03	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	74.10	116.44	24.35	1.76	2.12	0.00	1.41	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	62.63	107.94	25.99	1.33	1.33	0.00	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	47.37	82.52	21.39	1.02	0.51	0.00	2.04	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	77.11	117.93	28.28	3.47	2.40	0.27	1.33	0.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	79.73	131.88	32.31	2.46	2.46	0.19	2.08	0.38
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	28.22	69.95	12.88	1.84	1.23	0.61	1.84	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	58.71	92.14	21.20	0.82	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	88.50	152.85	41.23	2.71	2.71	0.42	2.92	0.83
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	65.58	109.02	25.50	4.48	4.20	0.56	5.61	1.68
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	50.49	89.64	14.42	0.00	2.06	0.00	1.03	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	80.99	141.09	30.19	2.32	2.90	1.16	4.35	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	68.75	113.29	27.20	3.59	2.39	0.60	1.79	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	70.82	123.38	31.54	1.66	0.55	0.00	0.00	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	57.26	98.27	26.87	2.12	0.35	0.00	1.06	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	45.73	87.77	23.60	1.84	2.21	0.74	1.48	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	33.39	62.17	9.21	2.30	0.00	1.15	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	44.90	86.34	21.87	2.30	0.77	0.00	1.15	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	34.53	68.50	16.42	0.57	0.00	0.57	2.26	1.70
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	34.46	76.30	19.69	1.64	1.64	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	43.38	78.18	13.56	2.26	0.45	0.00	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	48.83	91.20	16.52	1.44	1.44	0.00	2.15	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	62.74	105.31	26.14	0.75	0.00	0.75	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	56.48	88.81	24.90	2.60	0.37	0.00	2.23	1.11
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	52.55	112.43	24.12	3.02	2.58	0.86	2.58	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	53.09	107.04	23.12	5.14	0.00	0.86	0.00	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	67.30	109.62	28.32	3.00	1.00	0.00	1.00	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	35.60	88.08	14.48	1.21	0.60	0.00	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	33.42	76.79	16.35	0.71	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	54.31	78.37	26.12	1.03	0.00	0.00	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	41.87	83.20	11.27	2.68	1.61	0.54	2.15	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	39.05	68.68	14.81	0.67	0.67	0.00	1.35	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	50.01	96.68	24.82	2.22	0.37	0.37	1.85	1.11
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	41.87	73.26	12.79	0.00	2.33	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	29.62	55.00	8.46	0.00	0.00	1.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	66.02	113.64	27.21	0.80	1.60	0.80	0.40	1.20
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	34.89	56.70	10.90	2.18	0.00	0.00	0.73	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	40.63	52.12	17.63	0.77	0.00	0.00	0.00	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	39.46	67.58	11.35	1.48	1.97	0.99	0.99	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	17.88	70.57	6.59	3.76	1.88	0.94	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	41.23	59.84	16.09	1.51	0.00	0.00	0.00	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	54.53	90.58	20.73	2.25	0.90	0.00	1.80	1.35
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	27.54	67.12	15.49	0.00	0.00	1.72	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	45.87	71.70	14.70	2.23	0.00	0.45	0.45	0.89
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	47.31	73.12	20.33	1.96	0.78	0.39	0.39	1.17
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	31.67	67.29	12.53	2.64	0.66	0.00	1.98	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	46.70	74.73	16.61	1.04	0.00	0.00	1.04	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	49.01	92.33	22.32	1.31	0.00	0.00	3.50	1.75
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	41.93	95.61	18.45	0.56	2.80	0.00	1.12	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	41.96	91.42	16.78	1.77	0.44	0.88	1.32	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	57.09	90.26	21.99	1.54	2.31	0.39	1.54	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	41.52	99.25	16.71	1.52	1.52	0.00	2.03	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	45.18	96.12	17.78	2.40	1.92	0.48	0.00	1.92
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	57.64	99.39	27.83	2.39	0.40	0.00	0.40	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	32.81	102.08	25.52	1.82	1.82	1.22	3.04	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	34.59	74.70	14.53	2.08	0.00	0.00	1.38	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	56.24	86.26	24.70	1.52	1.52	0.00	1.14	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	24.79	79.01	14.46	2.07	2.58	0.00	3.61	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	28.42	87.07	21.77	0.60	0.00	0.00	0.00	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	60.21	108.38	26.94	2.22	1.90	0.32	2.22	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	28.79	84.23	11.19	2.13	1.07	0.00	1.60	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	20.11	58.62	16.67	1.72	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	50.39	90.51	22.11	2.57	0.51	1.54	1.54	2.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	36.78	90.54	14.85	0.71	0.00	0.00	2.83	1.41
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	18.73	82.29	17.02	2.84	0.57	0.00	2.27	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	55.33	101.09	24.13	0.83	0.00	0.42	1.25	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	44.63	93.18	8.61	0.78	0.78	0.00	1.57	1.57
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	25.47	75.99	18.37	1.25	0.00	0.84	0.42	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	35.31	83.17	19.05	1.86	0.93	0.00	0.46	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	29.44	76.27	18.06	2.01	1.34	0.00	2.68	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	33.15	108.00	23.52	3.21	0.53	0.53	1.07	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	41.22	86.88	22.23	2.42	0.40	0.40	0.81	0.81
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	17.44	76.17	12.85	1.84	0.92	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	16.89	81.80	16.00	1.78	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	47.30	87.76	17.67	3.99	0.57	0.00	1.71	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	19.94	73.62	6.90	0.77	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	41.04	118.19	25.72	2.74	1.64	0.55	1.64	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	41.87	88.64	19.15	2.67	0.45	0.00	0.45	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	46.27	77.99	16.64	0.78	0.00	0.00	0.52	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	28.51	89.52	21.88	1.33	0.00	0.66	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	37.41	112.24	18.71	4.16	0.00	0.00	2.08	0.00
Macrophage - monocyte derived, donor1	11232-116C8	82.96	72.71	49.46	0.68	2.73	0.46	0.23	0.68
Macrophage - monocyte derived, donor2	11313-117C8	44.96	68.45	28.26	1.10	0.37	0.18	0.18	0.37
Macrophage - monocyte derived, donor3	11389-118C3	71.31	88.09	44.04	1.70	0.26	0.00	0.13	0.66
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	23.36	48.85	11.15	0.53	1.06	0.53	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	61.00	94.91	21.23	2.22	0.48	0.00	1.27	0.32
Mallassez-derived cells, donor3	11930-125I4	63.93	119.95	29.19	1.81	0.69	1.11	1.11	0.56
Mammary Epithelial Cell, donor1	11273-116H4	117.28	104.82	40.26	2.79	4.38	2.69	0.90	0.80
Mammary Epithelial Cell, donor2	11350-117G9	103.37	130.88	39.96	3.76	1.74	4.05	1.16	0.29
Mammary Epithelial Cell, donor3	11422-118F9	54.13	45.40	22.95	1.25	0.25	0.75	0.75	1.00
Mast cell - stimulated, donor1	11487-119E2	403.37	666.41	260.33	11.52	0.00	6.78	3.39	0.00
Mast cell, donor1	11563-120D6	168.81	101.76	96.57	2.05	0.43	1.30	0.87	0.65
Mast cell, donor2	11565-120D8	319.76	430.90	191.38	8.62	0.89	2.38	0.59	2.67
Mast cell, donor3	11566-120D9	391.72	309.32	244.49	9.23	1.80	2.93	2.48	1.58
Mast cell, donor4	11567-120E1	288.63	428.33	179.24	9.40	0.71	1.42	0.89	1.60
Mast cell, expanded and stimulated, donor5	11940-126A5	144.38	126.53	104.35	2.66	0.22	3.11	1.33	1.11
Mast cell, expanded and stimulated, donor8	11942-126A7	77.63	145.92	74.71	3.50	0.58	2.92	0.00	1.17
Mast cell, expanded, donor5	11939-126A4	125.74	84.44	77.90	2.18	0.69	0.57	0.57	0.57
Mast cell, expanded, donor8	11941-126A6	124.86	108.12	82.85	2.68	0.33	0.50	0.50	0.84
Melanocyte - dark, donor1	11502-119F8	90.15	86.86	38.11	2.19	1.29	1.49	0.60	0.40
Melanocyte - dark, donor2	11582-120F7	74.75	79.25	36.68	3.46	0.35	0.35	0.69	0.00
Melanocyte - dark, donor3	11663-122F7	142.20	78.24	50.71	1.59	0.65	0.29	1.30	0.29
Melanocyte - light, donor1	11274-116H5	41.61	33.85	18.57	0.71	0.00	0.24	0.94	0.24
Melanocyte - light, donor2	11351-117H1	23.89	38.90	12.97	1.36	0.00	0.68	0.68	0.68
Melanocyte - light, donor3	11423-118G1	42.49	42.49	13.01	1.73	0.00	0.00	0.00	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	116.62	87.26	56.23	2.71	1.15	0.52	0.83	0.42
Melanocyte, donor2 (MC+2)	12739-135I3	86.87	51.91	29.85	2.15	6.45	0.54	1.08	0.81
Melanocyte, donor3 (MC+3)	12837-137B2	116.25	98.30	57.86	4.29	2.14	0.00	1.07	0.00
Meningeal Cells, donor1	11493-119E8	90.81	141.43	53.10	4.84	0.50	1.12	0.25	0.25
Meningeal Cells, donor2	11573-120E7	70.42	120.16	42.25	1.32	0.44	0.44	0.88	0.00
Meningeal Cells, donor3	11654-122E7	212.31	166.51	83.13	4.24	1.87	3.67	1.22	0.73
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	110.07	119.20	52.18	2.85	5.13	0.86	0.00	0.86
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	44.88	51.83	17.91	1.41	1.01	1.01	0.10	0.50
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	17.08	14.46	9.20	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	35.32	51.02	20.93	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	73.20	60.28	31.57	3.59	2.15	0.00	1.44	1.44
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	54.00	88.52	17.15	2.12	1.27	0.21	0.42	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	46.24	77.91	23.62	3.52	3.02	0.00	1.01	1.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	61.09	103.28	30.55	1.98	0.66	0.66	0.22	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	69.41	74.52	23.38	2.92	0.73	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	57.49	82.05	28.64	1.84	2.25	0.41	0.20	0.41
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	39.34	84.21	25.90	1.52	1.11	0.28	0.42	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	29.37	42.38	11.52	1.86	0.00	0.00	0.37	0.74
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	77.76	70.00	31.31	2.24	1.84	0.66	0.39	0.79
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	31.75	31.75	17.21	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	28.03	35.03	16.35	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	62.12	64.04	24.34	2.56	1.92	1.28	0.64	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	102.08	97.47	45.01	2.84	2.48	1.77	0.35	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	71.30	67.55	22.83	3.13	1.88	0.31	0.00	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	84.18	129.17	28.30	4.35	2.90	1.45	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	47.47	64.97	20.68	0.80	2.12	0.00	0.53	0.27
Mesothelial Cells, donor2	12156-128G5	30.53	48.04	12.01	1.00	0.00	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	61.93	68.72	20.81	1.45	1.30	0.29	1.66	1.08
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	126.93	170.14	56.71	1.35	0.00	0.00	1.35	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	60.83	83.98	34.72	2.71	1.72	0.00	0.99	0.74
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	55.06	70.08	26.21	1.47	1.18	0.00	2.94	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	51.86	76.06	27.66	3.46	0.00	0.00	0.00	3.46
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	43.39	54.24	17.98	2.79	0.93	0.31	0.62	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	39.62	59.53	23.23	0.83	1.66	0.00	1.87	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	64.85	64.85	23.16	2.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	49.80	89.09	31.28	0.00	1.00	0.25	0.75	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	55.39	86.11	37.24	0.93	0.47	0.00	1.40	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	97.33	77.86	97.33	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	50.19	77.02	30.48	1.83	1.22	0.00	0.61	0.81
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	49.10	76.02	28.51	1.19	0.40	0.00	1.19	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	34.21	102.62	34.21	8.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	24.78	67.26	15.93	0.88	0.00	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	41.03	69.91	24.70	1.52	1.90	0.00	0.76	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	64.48	93.43	32.90	0.00	0.00	0.00	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	45.42	106.54	24.83	1.49	2.12	0.00	1.06	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	39.60	56.17	18.42	0.00	0.00	0.00	2.76	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	46.20	127.27	23.55	0.60	0.60	0.30	1.19	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	38.56	51.98	25.15	1.68	1.68	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	169.75	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	37.13	130.72	25.09	3.01	1.00	0.00	0.50	0.50
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	43.26	78.67	22.34	0.71	0.48	0.00	4.04	1.43
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	49.76	117.76	27.09	2.21	0.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	35.69	132.16	23.72	1.38	1.15	0.46	1.61	0.69
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	39.33	70.46	22.51	1.26	0.63	0.00	0.63	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	46.27	118.42	23.64	2.24	0.41	0.00	0.20	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	38.62	90.11	17.59	2.36	1.72	0.00	0.64	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	41.35	80.69	18.45	2.45	0.67	0.22	0.00	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	20.64	72.23	20.64	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	32.41	122.87	18.84	1.10	1.10	0.00	0.88	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	41.57	84.15	17.74	2.03	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	26.51	122.62	26.51	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	46.75	130.46	21.47	2.72	0.82	0.00	1.36	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	37.35	76.17	21.47	1.47	1.18	0.00	0.29	0.59
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	46.88	107.94	19.63	1.09	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	25.47	82.66	13.94	1.44	0.48	0.00	0.48	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	29.62	66.44	16.81	1.20	0.80	0.00	2.00	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	45.25	83.64	10.97	1.37	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	28.03	81.59	17.02	2.00	1.00	0.50	2.00	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	53.89	53.89	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	44.85	85.62	18.35	6.12	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	38.54	84.52	20.58	1.75	1.75	0.44	0.88	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	28.69	76.15	17.66	1.10	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	61.48	71.08	23.69	4.48	0.00	0.00	0.00	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	44.63	85.53	28.26	2.73	0.50	0.00	0.50	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	36.88	74.46	26.44	4.87	0.70	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	59.67	106.07	28.73	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	50.60	67.35	22.56	1.37	1.71	0.00	2.39	0.68
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	36.76	96.28	22.76	1.31	0.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	69.24	83.80	42.26	1.78	0.00	0.00	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	48.82	73.22	23.01	3.09	1.68	0.00	0.56	1.12
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	39.90	64.01	12.05	2.49	0.00	0.00	0.00	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	58.86	65.27	34.38	2.33	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	54.30	74.51	28.66	1.51	0.60	0.00	0.00	0.60
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	34.64	83.06	19.20	0.83	0.83	0.42	1.25	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	43.31	57.75	14.44	21.66	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	35.10	50.80	30.48	0.00	0.92	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	42.11	100.16	23.90	1.71	0.00	0.00	0.57	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	64.81	71.99	36.07	2.35	0.14	0.00	0.00	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	43.54	62.97	19.70	1.55	1.30	0.00	0.26	1.04
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	42.04	96.95	20.16	0.86	0.00	0.00	0.43	0.86
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	59.71	51.45	27.31	2.54	0.00	0.00	0.00	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	52.04	68.59	29.62	1.60	0.27	0.00	0.80	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	45.20	88.30	30.23	2.10	1.50	0.30	0.60	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	63.14	59.47	32.77	2.12	0.28	0.00	0.28	0.28
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	36.63	59.56	19.11	1.91	0.64	0.00	0.32	0.64
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	41.13	91.33	22.78	1.99	0.22	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	51.57	53.85	26.16	1.90	0.00	0.00	0.76	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	44.60	59.66	26.71	1.70	0.57	0.00	0.28	0.57
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	37.36	77.92	25.07	1.72	1.23	0.00	0.49	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	48.88	63.86	35.19	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	46.46	69.10	22.35	2.35	0.59	0.00	0.00	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	51.90	85.06	22.78	3.17	1.15	0.00	0.58	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	81.60	92.73	44.10	1.65	0.82	0.00	0.41	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	56.28	67.60	39.01	1.19	0.30	0.00	0.30	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	30.14	18.83	26.37	3.77	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	32.08	28.52	8.91	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	68.34	53.56	33.84	2.30	1.31	0.33	0.66	1.31
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	31.56	48.39	16.83	2.10	4.21	0.00	0.00	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	41.32	46.46	25.11	0.59	0.40	0.00	0.59	0.59
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	63.33	67.06	32.60	0.00	1.86	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	70.98	71.73	25.91	1.13	3.00	0.00	1.50	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	44.48	42.61	21.84	1.07	1.33	0.00	0.53	1.07
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	45.13	55.08	25.90	0.90	0.68	0.11	0.00	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	38.31	51.57	25.79	2.21	1.47	0.00	1.47	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	53.50	53.13	26.38	0.37	0.37	0.37	1.83	1.10
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	60.67	56.00	31.11	0.00	1.56	0.00	4.67	4.67
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	32.07	31.00	19.24	1.07	0.53	0.53	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	23.18	27.05	15.46	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	49.49	40.40	29.29	1.01	1.01	0.00	1.01	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	30.36	30.36	11.81	0.42	0.84	0.00	0.00	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	21.79	111.68	8.17	0.00	1.36	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	7.63	12.72	3.18	0.00	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	12.15	25.10	3.24	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	22.66	28.70	10.57	3.02	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	108.49	559.60	62.81	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	52.20	309.93	48.94	3.26	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	9.50	161.58	19.01	14.26	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	25.10	313.73	25.10	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	68.51	78.20	21.97	1.72	0.65	0.00	0.43	0.65
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	71.60	59.58	30.31	3.66	1.57	0.52	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	39.38	42.05	20.02	3.34	1.33	0.67	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	23.37	23.37	9.60	2.09	0.83	0.00	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	43.92	38.98	19.96	1.33	0.38	1.33	0.95	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	193.10	221.82	70.22	12.77	1.60	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	22.44	32.64	8.84	0.68	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	102.91	113.93	49.62	14.70	1.84	3.68	3.68	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	21.76	39.76	15.07	0.84	0.42	0.00	0.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	29.05	36.03	12.32	1.16	0.93	0.70	0.23	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	33.78	31.89	13.78	1.89	0.81	0.00	0.27	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	71.69	75.47	33.22	3.15	1.05	0.21	0.63	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	334.04	144.75	89.08	0.00	22.27	0.00	11.13	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	32.76	41.20	16.88	2.48	0.50	0.00	0.99	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	28.42	18.13	10.56	0.81	0.81	0.27	0.27	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	26.30	31.74	9.97	0.68	0.45	0.45	0.68	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	21.88	27.27	13.88	1.47	0.33	0.00	0.16	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	68.89	76.73	32.26	2.19	1.28	0.18	0.55	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	25.99	37.66	15.91	1.06	1.06	0.53	0.53	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	28.21	43.82	15.01	3.00	0.00	0.60	1.20	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	35.44	30.85	10.17	0.33	0.66	0.33	2.63	1.31
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	22.60	27.81	10.57	0.65	0.98	0.00	0.16	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	94.54	104.42	41.45	3.88	0.35	0.35	1.06	0.35
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	35.86	30.94	18.99	0.00	0.00	0.00	2.81	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	24.36	31.26	10.57	0.92	0.92	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	41.45	40.81	20.24	1.29	0.64	0.32	0.64	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	35.18	27.59	13.11	1.03	0.00	1.03	2.41	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	194.69	78.38	40.46	7.59	2.53	5.06	12.64	5.06
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	79.31	86.44	29.85	2.45	0.45	0.89	0.45	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	23.71	35.99	10.16	2.54	0.42	0.42	1.27	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	24.21	25.87	8.78	1.90	0.00	0.24	1.42	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	37.77	43.35	13.74	0.86	0.43	0.86	0.00	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	243.75	225.69	63.19	9.03	27.08	0.00	36.11	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	29.66	39.32	15.99	1.33	0.67	0.00	0.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	63.12	67.18	25.25	2.71	1.35	0.45	1.35	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	19.44	33.73	13.89	1.59	0.79	0.40	0.00	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	26.00	35.29	13.00	1.86	0.00	0.93	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	28.76	32.54	11.73	0.76	0.00	0.76	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	21.83	34.54	12.71	1.63	0.33	0.33	0.65	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	30.50	25.71	10.02	0.44	0.00	0.00	0.87	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	75.53	91.36	37.54	2.26	0.00	0.45	0.90	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	28.22	47.62	14.11	3.53	0.88	0.88	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	28.59	45.87	13.30	0.00	1.33	0.66	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	41.67	54.07	14.88	0.99	0.50	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	20.67	32.92	14.55	1.53	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	47.48	52.63	17.84	3.33	1.51	0.00	0.00	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	63.65	81.34	24.75	2.65	0.22	0.22	0.00	0.44
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	17.62	33.88	10.84	1.36	0.00	1.36	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	143.07	102.19	81.75	0.00	5.11	0.00	10.22	5.11
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	28.66	45.12	17.68	1.83	2.44	0.00	0.61	1.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	22.03	28.64	8.50	0.94	0.31	0.31	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	26.94	33.59	11.50	2.42	0.91	0.00	0.30	0.91
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	28.48	34.81	18.20	0.00	0.00	0.00	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	31.74	39.68	9.07	2.27	2.27	1.13	5.67	2.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	141.62	116.33	20.23	10.12	5.06	10.12	5.06	5.06
Myoblast, donor1	11241-116D8	63.98	79.38	22.49	1.37	1.37	0.62	0.25	0.75
Myoblast, donor2	11322-117D8	92.83	104.33	42.96	4.41	3.07	0.77	2.30	1.92
Myoblast, donor3	11398-118D3	90.64	113.17	38.68	3.20	1.01	0.67	0.50	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	193.65	90.92	57.35	2.77	3.21	0.58	2.63	0.44
Natural Killer Cells, donor1	11230-116C6	291.53	54.43	106.40	2.15	3.38	3.08	1.54	1.54
Natural Killer Cells, donor2	11311-117C6	304.87	49.46	77.80	3.92	6.63	2.41	3.92	1.21
Natural Killer Cells, donor3	11387-118C1	279.58	63.50	84.48	1.66	2.58	2.21	5.34	2.39
Neural stem cells, donor1	11275-116H6	246.44	163.32	90.01	6.53	2.18	4.72	0.00	11.25
Neural stem cells, donor2	11352-117H2	363.95	217.60	134.80	3.85	0.00	7.70	0.00	1.93
Neurons, donor1	11494-119E9	192.30	145.65	73.96	3.41	1.14	2.28	1.14	0.00
Neurons, donor2	11574-120E8	190.88	100.61	81.46	4.62	2.20	2.42	1.54	0.88
Neurons, donor3	11655-122E8	134.84	82.22	47.69	1.64	1.64	3.29	1.64	2.47
Neutrophils, donor1	11233-116C9	254.27	128.99	159.62	4.64	0.00	0.93	3.71	3.71
Neutrophils, donor2	11314-117C9	211.62	130.45	118.85	5.80	0.00	0.00	14.49	17.39
Neutrophils, donor3	11390-118C4	255.94	142.33	186.31	5.50	0.00	2.44	2.44	4.28
Nucleus Pulposus Cell, donor1	11252-116F1	145.33	117.67	64.59	5.22	2.02	0.00	0.59	0.59
Nucleus Pulposus Cell, donor2	11409-118E5	60.89	64.80	28.65	2.60	3.58	0.65	0.65	0.98
Nucleus Pulposus Cell, donor3	11462-119B4	36.30	65.78	21.66	1.60	0.80	0.20	0.20	0.00
Olfactory epithelial cells, donor1	11933-125I7	44.46	38.13	17.89	1.51	1.51	0.41	1.10	0.83
Olfactory epithelial cells, donor2	11934-125I8	59.35	54.57	28.51	1.88	2.89	1.01	2.46	1.88
Olfactory epithelial cells, donor3	11935-125I9	48.47	55.96	22.70	1.70	2.95	0.57	0.57	0.45
Olfactory epithelial cells, donor4	11936-126A1	65.65	61.46	31.17	1.75	0.97	0.39	0.29	0.39
Oligodendrocyte - precursors, donor1	11496-119F2	90.27	114.95	32.50	3.01	0.60	0.60	0.60	0.00
Osteoblast - differentiated, donor1	11276-116H7	44.67	53.17	18.29	1.70	0.85	0.21	0.00	0.64
Osteoblast - differentiated, donor2	11353-117H3	21.72	36.58	5.72	1.14	0.00	0.00	0.00	2.29
Osteoblast - differentiated, donor3	11425-118G3	40.97	41.59	17.38	0.62	0.00	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	64.30	51.40	32.44	0.98	0.98	1.17	0.39	0.00
Osteoblast, donor2	11354-117H4	160.83	172.07	70.23	2.81	1.40	7.02	1.40	0.00
Osteoblast, donor3	11426-118G4	87.09	67.18	39.81	2.67	0.00	1.07	1.78	0.36
Pancreatic stromal cells, donor1	11249-116E7	114.56	107.48	50.88	3.45	2.11	1.43	1.26	0.76
Pericytes, donor1	11491-119E6	15.80	28.60	13.80	0.78	0.22	0.00	0.45	0.00
Pericytes, donor2	11571-120E5	21.96	25.81	14.94	1.81	0.00	0.00	0.00	0.23
Pericytes, donor3	11652-122E5	49.03	44.15	14.85	0.81	2.24	0.41	0.61	0.20
Perineurial Cells, donor1	11499-119F5	107.71	84.88	45.89	2.26	1.02	0.57	0.00	0.34
Perineurial Cells, donor2	11579-120F4	119.43	109.31	50.61	3.86	0.92	0.55	0.46	0.18
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	335.63	118.57	130.05	2.87	0.64	2.23	0.64	1.27
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	220.38	81.78	66.60	2.45	3.67	1.96	1.71	0.49
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	279.80	72.21	95.38	1.94	1.04	1.04	0.91	1.04
Placental Epithelial Cells, donor1	11278-116H9	63.14	69.60	26.55	2.87	1.43	0.24	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	53.23	69.86	19.96	0.00	1.11	1.11	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	88.94	57.13	34.75	2.75	0.59	0.20	0.98	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	16.46	16.46	6.33	0.95	0.00	0.00	0.63	0.32
Preadipocyte - breast, donor1	11467-119B9	37.52	50.84	16.13	2.06	1.31	0.38	0.00	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	110.03	96.85	45.55	2.87	0.91	0.00	0.39	0.13
Preadipocyte - breast, donor2	11328-117E5	53.59	51.56	18.91	2.93	1.35	0.00	0.90	0.68
Preadipocyte - omental, donor1	11468-119C1	53.92	61.16	20.35	2.13	1.70	0.11	0.00	0.21
Preadipocyte - omental, donor2	11329-117E6	45.39	58.92	17.02	2.62	0.87	0.00	0.44	1.31
Preadipocyte - omental, donor3	11403-118D8	64.61	64.75	27.36	2.29	0.43	0.14	0.29	1.00
Preadipocyte - perirenal, donor1	11469-119C2	16.73	40.35	3.94	0.00	0.00	0.00	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	39.00	35.32	14.13	0.92	0.00	1.54	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	159.19	197.62	71.89	7.61	7.26	1.95	2.30	1.95
Preadipocyte - subcutaneous, donor3	11428-118G6	86.50	67.94	40.02	2.38	1.53	1.02	1.19	0.34
Preadipocyte - visceral, donor1	11280-116I2	134.32	145.87	71.44	3.63	3.07	3.63	0.37	0.84
Preadipocyte - visceral, donor2	11357-117H7	107.68	112.74	49.70	3.22	1.84	0.92	0.46	1.38
Preadipocyte - visceral, donor3	11429-118G7	65.20	92.68	39.18	3.55	2.82	1.46	1.15	0.63
Prostate Epithelial Cells (polarized), donor1	11253-116F2	198.67	182.23	64.26	3.92	2.87	3.77	1.81	1.96
Prostate Epithelial Cells, donor2	11331-117E8	53.76	65.40	19.36	1.76	1.49	0.14	0.81	0.27
Prostate Epithelial Cells, donor3	11404-118D9	63.07	91.30	30.25	3.80	0.43	0.31	2.33	1.65
Prostate Stromal Cells, donor1	11254-116F3	113.90	129.16	37.81	3.42	1.94	1.48	1.14	0.46
Prostate Stromal Cells, donor2	11332-117E9	120.13	131.07	42.85	4.48	5.20	1.97	3.77	1.43
Prostate Stromal Cells, donor3	11405-118E1	64.13	76.96	28.26	2.92	1.46	0.31	1.46	0.83
Renal Cortical Epithelial Cells, donor1	11516-119H4	42.70	61.68	16.42	0.73	0.36	0.36	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	90.17	85.25	30.64	2.22	1.04	0.97	0.28	0.42
Renal Epithelial Cells, donor1	11517-119H5	53.77	84.71	28.91	1.52	0.51	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	56.19	76.11	28.45	2.13	0.71	0.71	0.71	0.00
Renal Epithelial Cells, donor3	11678-122H4	113.49	104.07	42.13	3.07	1.48	0.95	1.16	0.53
Renal Glomerular Endothelial Cells, donor1	11514-119H2	23.15	62.64	10.21	2.04	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	36.12	78.03	26.14	2.56	0.40	0.54	0.40	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	128.54	175.39	59.72	6.88	1.11	0.89	4.22	2.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	49.24	44.58	14.64	2.00	0.00	0.00	1.33	0.00
Renal Mesangial Cells, donor1	11518-119H6	55.68	86.71	28.39	2.20	0.00	0.44	0.44	0.22
Renal Mesangial Cells, donor2	11598-120H5	51.41	73.36	25.08	5.02	1.25	0.00	1.25	0.00
Renal Mesangial Cells, donor3	11679-122H5	23.03	33.57	11.10	1.11	0.83	0.00	0.28	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	79.99	161.32	27.11	3.49	1.07	0.54	0.54	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	32.05	61.57	13.92	0.42	1.69	0.42	0.42	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	78.10	82.54	31.43	4.05	3.09	0.39	0.39	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	101.12	100.86	47.97	2.85	4.93	1.04	1.04	1.30
Retinal Pigment Epithelial Cells, donor1	11528-119I7	60.54	81.58	33.83	2.84	0.28	0.28	0.85	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	42.19	51.46	21.61	3.09	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	98.36	96.85	35.63	0.25	1.76	2.76	1.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	141.39	176.53	58.27	2.54	0.40	0.80	0.94	6.68
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	67.01	36.63	36.63	0.00	0.00	0.00	0.89	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	113.38	86.96	62.74	4.40	0.00	0.55	4.40	6.60
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	231.44	142.11	104.41	6.38	0.00	0.00	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	84.39	89.72	45.12	2.34	1.04	0.39	1.04	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	135.15	64.75	47.57	2.48	2.48	0.20	1.49	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	143.33	76.63	46.29	2.79	1.45	0.56	0.45	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	119.58	105.06	62.77	3.60	2.98	1.36	1.98	0.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	144.40	69.11	50.35	3.85	2.56	0.70	2.21	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	139.83	88.75	46.92	3.24	3.00	0.92	0.92	1.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	84.34	74.62	46.41	2.60	0.82	0.68	0.82	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	122.53	71.70	32.98	2.12	0.76	0.45	1.97	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	125.07	75.98	40.86	2.69	1.79	0.36	0.36	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	82.06	78.33	40.45	2.58	1.15	0.43	2.73	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	123.30	67.39	42.07	3.97	1.82	0.86	1.07	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	119.49	69.48	37.17	2.21	2.88	0.89	0.89	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	90.81	96.54	44.54	2.87	0.38	0.38	0.38	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	136.86	72.11	45.56	2.98	1.30	0.47	0.65	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	169.87	110.87	53.74	3.19	0.38	0.75	0.75	1.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	95.02	81.48	44.85	3.32	0.40	0.66	1.06	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	145.52	74.27	46.04	3.31	0.68	0.49	1.27	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	125.84	70.85	45.45	3.63	2.29	1.15	1.34	1.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	87.57	81.38	41.33	2.24	0.85	0.43	1.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	114.64	66.15	35.88	2.24	2.24	0.56	1.96	1.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	145.26	84.08	50.07	3.08	1.71	0.51	1.20	1.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	81.68	73.11	39.02	3.10	0.91	0.73	0.73	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	133.67	67.69	43.78	2.58	1.47	0.49	1.35	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	121.83	73.74	44.33	2.82	1.61	0.54	1.88	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	80.43	100.48	46.00	2.12	1.89	1.42	2.36	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	131.94	67.66	44.44	0.79	2.98	0.99	0.79	1.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	124.41	64.54	32.97	3.98	3.27	0.94	0.70	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	77.34	88.96	41.68	1.66	0.62	0.41	1.45	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	112.15	73.00	33.40	4.65	1.55	0.22	1.55	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	137.45	82.51	48.67	1.67	1.46	0.63	1.25	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	103.90	93.54	46.57	2.56	0.67	0.40	0.81	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	158.20	74.08	51.94	2.38	0.51	0.51	0.85	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	146.52	88.11	45.89	4.63	0.96	1.35	1.74	0.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	105.23	105.23	50.89	3.61	0.86	1.38	1.03	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	147.46	66.12	42.52	3.84	0.82	0.55	1.78	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	137.25	79.62	44.65	3.61	1.97	0.99	1.15	1.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	83.51	85.39	43.12	3.75	0.00	0.68	0.68	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	155.36	80.78	52.67	4.59	1.48	0.59	0.74	1.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	145.80	101.02	50.11	2.67	0.80	0.53	0.53	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	73.83	76.05	43.00	3.18	0.97	0.14	0.97	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	110.24	53.10	36.91	1.67	3.81	0.48	0.95	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	192.47	116.09	76.99	4.64	0.40	0.81	0.81	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	71.57	57.82	35.41	1.79	0.57	0.38	0.75	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	109.70	73.72	37.38	2.79	3.14	0.00	1.40	1.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	126.02	63.46	39.89	1.21	0.60	0.60	1.51	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	76.86	57.77	35.49	1.71	0.86	0.61	0.73	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	219.20	98.68	67.10	2.33	1.46	0.44	1.31	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	101.00	51.11	35.29	3.04	1.83	0.00	0.00	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	65.40	52.74	34.66	1.21	0.90	0.60	0.60	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	118.07	64.01	47.27	2.49	2.04	0.23	0.90	6.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	135.69	68.59	50.92	3.59	1.50	0.60	0.60	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	71.91	70.25	31.29	1.30	0.59	0.47	0.59	7.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	100.11	50.16	33.30	1.28	0.85	0.21	1.49	7.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	116.59	64.91	42.67	2.40	0.00	0.60	1.20	0.00
Schwann Cells, donor1	11498-119F4	37.43	59.99	25.01	3.20	0.38	0.19	0.94	0.00
Schwann Cells, donor2	11578-120F3	102.07	74.85	40.83	3.40	0.00	0.00	3.40	3.40
Schwann Cells, donor3	11659-122F3	79.09	91.36	43.16	1.97	3.94	0.88	2.63	1.10
Sebocyte, donor1	11220-116B5	138.59	142.42	52.04	2.74	0.00	1.10	0.00	0.00
Sebocyte, donor2	11301-117B5	97.89	90.53	29.41	4.14	0.92	0.46	1.84	0.46
Sebocyte, donor3	11378-118B1	54.62	42.05	23.91	2.06	1.03	0.00	0.00	0.00
Sertoli Cells, donor1	11255-116F4	120.93	110.99	39.76	0.00	1.66	0.00	0.00	1.66
Sertoli Cells, donor2	11333-117F1	64.96	81.91	16.95	0.00	11.30	0.00	5.65	2.82
Skeletal Muscle Cells, donor1	11281-116I3	137.51	114.55	56.13	2.82	2.90	3.17	1.06	1.23
Skeletal Muscle Cells, donor2	11358-117H8	14.46	15.18	6.51	0.72	0.72	1.45	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	75.24	77.75	40.13	0.84	0.00	0.00	1.67	0.00
Skeletal Muscle Cells, donor4	11451-119A2	94.57	155.37	53.10	3.61	1.73	2.98	0.94	0.47
Skeletal Muscle Cells, donor5	11455-119A6	87.11	146.56	54.40	6.24	2.68	1.49	0.45	0.30
Skeletal Muscle Cells, donor6	11459-119B1	98.81	168.83	57.41	5.08	1.08	3.39	1.23	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	145.29	129.79	71.70	3.91	2.39	0.25	1.26	0.25
Skeletal Muscle Satellite Cells, donor2	11321-117D7	142.12	133.56	63.92	6.42	2.85	0.71	1.71	1.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	195.44	192.37	80.76	7.34	1.88	2.28	0.79	0.79
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	147.69	109.70	52.40	2.02	1.77	2.44	0.42	0.51
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	73.10	66.59	34.74	2.17	0.72	0.72	1.45	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	20.92	32.34	12.11	1.10	0.28	0.83	0.00	0.00
Skin - palm, donor1	10286-104F7	59.09	18.80	32.23	2.69	0.00	2.69	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	22.49	49.88	14.85	1.30	0.58	0.14	1.30	0.72
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	46.62	126.77	32.72	1.64	0.00	1.64	0.82	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	28.82	58.94	16.36	2.60	0.26	1.04	0.65	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	75.06	85.21	23.21	2.36	2.09	0.56	0.56	1.25
Small Airway Epithelial Cells, donor2	11334-117F2	82.85	82.57	28.13	2.25	1.27	0.70	0.70	0.28
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	135.96	207.64	79.29	4.44	0.42	1.27	0.21	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	94.14	118.20	41.67	3.37	0.30	0.45	1.20	0.52
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	22.84	37.96	12.65	1.23	0.31	0.31	0.31	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	66.25	100.05	49.36	3.33	0.00	0.44	0.44	0.67
Smooth Muscle Cells - Aortic, donor0	11210-116A4	47.61	41.15	24.10	1.18	0.00	0.59	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	89.06	97.24	48.40	3.31	0.44	0.66	0.00	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	44.89	64.97	24.02	0.79	0.39	0.79	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	44.81	53.31	20.09	0.77	0.00	0.77	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	80.06	100.08	32.02	7.01	1.00	0.00	2.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	52.96	54.30	26.48	1.86	1.33	0.27	0.27	0.40
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	70.93	61.62	29.26	1.11	3.32	1.33	0.89	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	35.59	48.14	17.16	1.02	0.51	0.13	0.26	0.38
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	78.47	73.91	38.42	2.60	1.30	0.65	1.30	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	66.74	67.63	28.65	1.77	1.77	0.89	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	57.80	60.08	23.35	0.57	0.14	0.00	0.71	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	21.31	43.43	12.85	0.49	0.16	0.00	0.00	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	73.67	87.37	36.23	2.74	0.30	0.00	0.00	0.91
Smooth Muscle Cells - Carotid, donor1	11285-116I7	68.44	45.71	31.07	1.77	0.25	0.51	0.00	0.51
Smooth Muscle Cells - Carotid, donor2	11362-117I3	177.50	232.59	97.93	12.24	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	21.46	24.32	16.69	1.43	0.00	0.00	0.48	0.95
Smooth Muscle Cells - Colonic, donor1	11239-116D6	67.99	88.93	33.18	2.51	1.77	0.59	0.44	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	77.27	100.73	34.01	4.95	2.37	0.65	0.22	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	93.73	112.41	41.04	3.78	0.94	1.05	1.36	0.31
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	56.15	64.19	24.44	2.32	0.46	1.24	0.15	0.77
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	18.32	47.43	12.93	0.00	1.08	0.00	0.00	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	34.37	51.70	19.13	1.20	0.30	0.30	0.00	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	38.24	67.60	24.58	4.44	0.34	0.00	1.02	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	106.56	94.08	44.45	2.91	1.49	0.63	1.18	0.47
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	78.10	91.28	35.12	3.12	2.21	1.61	0.30	1.81
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	86.70	88.75	25.71	2.05	5.92	0.68	1.14	0.91
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	16.30	36.23	16.91	0.60	0.60	0.60	0.60	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	188.89	292.48	93.25	8.21	0.79	6.09	1.59	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	54.73	122.37	36.22	2.40	0.93	1.46	0.53	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	77.51	104.06	34.31	4.63	2.38	0.75	1.13	1.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	39.06	38.30	16.74	1.01	0.25	0.25	0.25	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	77.65	80.51	34.83	2.56	1.51	1.21	0.45	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	43.51	52.51	18.00	2.25	3.75	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	126.64	222.26	111.13	7.75	0.00	0.00	0.00	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	61.39	40.93	23.25	1.86	0.00	0.00	0.93	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	50.99	55.54	16.66	1.01	3.03	0.50	1.01	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	26.33	40.74	9.72	1.25	0.63	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	15.34	34.22	9.14	0.29	0.00	0.00	0.00	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	196.94	216.51	96.55	5.25	1.42	3.92	0.75	0.33
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	78.95	76.15	35.04	2.34	2.34	0.47	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	45.05	32.67	16.55	0.58	0.29	0.86	0.43	0.29
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	63.74	47.93	28.30	0.76	0.25	0.25	0.00	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	30.46	38.36	18.24	1.32	0.94	1.13	0.75	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	118.22	144.91	54.22	5.31	0.84	2.24	0.14	0.56
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	59.57	66.86	28.74	1.42	0.92	0.75	0.34	0.25
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	10.95	16.67	7.62	0.95	0.95	0.00	0.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	50.64	29.36	21.04	0.73	0.73	0.49	0.49	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	46.84	103.85	27.62	2.43	2.21	0.44	1.10	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	41.55	43.89	20.48	2.63	0.59	0.59	0.29	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	51.89	57.34	23.32	0.97	0.58	0.19	0.58	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	31.73	49.45	16.40	1.59	0.53	0.00	0.79	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	33.10	53.56	18.23	2.98	0.74	0.00	1.49	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	43.12	86.60	24.79	1.08	1.08	0.00	0.36	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	24.42	75.80	15.05	1.99	0.57	0.57	0.85	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	74.44	119.74	29.15	2.76	1.18	1.97	1.58	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	35.81	52.82	18.28	0.76	0.76	0.25	1.02	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	42.73	43.53	21.96	2.00	1.20	0.00	0.40	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	33.86	53.09	15.05	2.51	1.25	0.42	0.42	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	28.88	48.13	17.88	2.29	2.29	0.00	1.38	0.46
Synoviocyte, donor1	11291-117A4	85.84	80.12	32.15	1.01	1.68	0.17	1.18	0.17
Synoviocyte, donor2	11368-117I9	68.73	45.93	22.13	2.35	0.84	0.00	0.84	0.00
Synoviocyte, donor3	11440-118H9	38.87	50.27	16.98	1.79	1.12	0.45	0.67	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	98.62	127.21	39.66	2.86	0.00	0.71	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	33.69	45.59	25.77	0.00	1.98	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	64.14	50.48	24.54	2.55	1.16	0.46	0.23	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	62.87	84.80	27.31	2.01	1.86	0.43	0.29	0.50
Tracheal Epithelial Cells, donor2	11369-118A1	29.77	40.20	10.82	1.93	0.00	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	13.17	30.35	12.60	1.15	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	143.82	179.74	57.94	2.83	0.86	0.25	0.12	6.27
Urethra, donor2	10319-105A4	147.47	136.68	50.36	8.99	0.00	0.00	3.60	0.00
Urothelial Cells, donor1	11520-119H8	30.29	47.82	14.61	0.00	0.53	0.00	0.53	0.00
Urothelial Cells, donor2	11600-120H7	28.04	33.25	11.62	0.40	0.80	0.00	0.40	0.00
Urothelial Cells, donor3	11681-122H7	28.65	27.50	10.77	1.15	0.92	0.00	0.23	0.46
Urothelial cells, donor0	11216-116B1	71.33	50.82	26.08	1.56	2.01	0.00	0.67	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	107.66	95.21	99.66	2.67	0.00	1.78	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	131.52	110.08	94.35	1.43	10.01	1.43	0.00	2.86
Whole blood (ribopure), donor090309, donation3	12181-129A3	158.81	88.99	78.72	0.68	9.58	0.00	0.68	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	216.59	91.59	105.37	1.03	3.79	2.75	0.69	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	173.15	72.05	95.29	4.65	9.30	1.16	0.00	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	97.88	111.41	85.38	3.12	4.16	2.08	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	105.55	125.74	82.60	0.00	2.75	1.84	1.84	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	145.15	62.08	81.25	2.74	11.87	0.00	0.91	0.91
Wilms' tumor cell line:G-401	10809-111A8	191.21	151.12	58.10	4.93	3.58	5.80	2.71	1.73
Wilms' tumor cell line:HFWT	10597-108E3	131.13	83.60	51.92	9.68	0.00	0.00	0.88	1.76
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	153.90	139.10	67.87	5.87	4.47	3.91	3.07	0.56
achilles tendon, donor2	10292-104G4	103.33	171.52	70.26	4.13	0.00	0.00	0.00	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	264.39	250.11	112.69	6.63	4.08	3.82	2.80	3.31
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	433.93	258.64	128.39	6.50	5.34	2.09	0.93	0.93
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	367.88	190.88	130.34	4.15	1.42	3.09	1.07	0.59
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	314.02	258.24	95.78	4.90	2.45	7.62	4.63	2.18
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	316.22	261.97	152.91	11.52	8.99	10.12	13.49	4.50
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	148.04	96.65	76.98	2.96	1.06	0.21	0.42	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	138.28	248.26	98.27	10.07	2.72	2.99	1.63	1.91
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	171.41	155.55	78.43	3.08	3.53	3.08	3.53	2.64
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	139.66	199.28	88.21	5.72	2.45	2.04	2.45	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	318.79	307.14	64.07	5.82	4.66	9.32	6.60	2.33
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	217.12	310.96	122.36	10.86	5.34	9.94	8.46	2.58
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	163.82	206.73	101.41	3.90	0.00	3.90	7.80	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	159.88	264.22	100.85	4.88	3.02	3.49	6.74	2.32
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	348.48	487.77	90.87	5.95	8.28	14.76	6.99	1.81
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	315.04	482.79	112.51	7.60	5.84	5.55	17.83	8.48
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	240.28	536.33	93.42	10.22	1.86	0.46	1.86	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	157.51	110.22	64.57	2.47	1.23	0.82	1.65	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	151.94	429.12	77.66	4.60	0.92	2.46	3.99	0.92
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	416.47	633.66	99.42	10.24	2.13	13.23	3.41	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	428.86	671.19	116.77	8.49	3.03	10.62	1.52	1.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	423.16	672.29	125.65	8.67	4.81	13.72	1.68	1.68
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	219.17	387.79	108.47	13.59	2.90	2.90	4.68	3.12
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	361.23	290.52	159.77	13.34	2.00	2.00	3.00	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	314.04	367.92	139.37	13.01	0.00	5.57	1.86	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	166.48	224.11	97.18	6.78	1.88	3.77	1.88	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	332.33	274.33	147.85	6.54	1.74	5.67	1.74	0.87
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	448.00	316.78	146.21	11.25	0.00	3.75	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	159.20	102.91	57.23	2.83	0.24	0.71	0.71	0.47
adipose tissue, adult, pool1	10010-101C1	147.21	125.96	57.39	2.64	0.16	0.78	0.31	8.07
adipose, donor1	10184-103D4	186.48	160.68	81.51	16.42	15.25	4.10	5.86	8.21
adipose, donor2	10185-103D5	70.97	77.45	42.98	12.98	7.30	1.62	1.22	1.22
adipose, donor3	10186-103D6	150.85	116.27	53.64	5.99	6.26	2.18	4.08	3.81
adipose, donor4	10187-103D7	262.63	420.37	109.21	3.47	15.60	7.80	12.13	6.93
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	275.40	219.21	81.28	9.15	2.68	1.26	1.89	0.63
adrenal gland, adult, pool1	10081-102A9	54.57	94.58	25.46	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	108.06	98.19	67.50	8.00	1.20	0.53	0.93	1.20
alveolar cell carcinoma cell line:SW 1573	10708-109H6	209.38	123.98	82.18	3.93	11.43	4.29	1.07	3.22
amniotic membrane cells, donor1	12235-129G3	71.18	50.08	35.01	0.93	0.23	0.23	0.23	0.00
amniotic membrane cells, donor2	12236-129G4	123.41	125.77	45.98	3.72	1.01	0.00	0.00	0.00
amniotic membrane cells, donor3	12237-129G5	80.13	83.96	30.64	3.24	0.59	0.29	0.00	0.59
amygdala - adult, donor10196	10167-103B5	132.81	173.13	56.92	7.11	2.37	0.00	2.37	3.56
amygdala, adult, donor10252	10151-102I7	180.06	170.73	73.81	5.47	1.22	1.62	1.01	1.22
amygdala, newborn, donor10223	10360-105E9	69.07	96.83	44.22	5.49	1.94	2.26	0.65	1.29
anaplastic carcinoma cell line:8305C	10428-106D5	79.45	64.05	34.12	1.53	1.15	0.00	0.13	0.64
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	270.48	196.13	125.98	8.60	8.60	1.54	6.84	1.99
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	213.45	102.88	114.57	4.01	3.67	2.34	2.34	2.00
aorta, adult, pool1	10052-101G7	118.66	98.26	62.37	3.33	1.37	1.18	1.96	0.98
appendix, adult	10189-103D9	227.44	158.74	93.15	4.27	1.16	0.00	2.33	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	224.93	134.13	68.44	8.94	1.72	3.78	2.06	0.69
artery, adult	10190-103E1	116.85	119.56	43.48	5.43	2.72	0.00	2.72	2.72
astrocytoma cell line:TM-31	10425-106D2	193.11	125.74	80.84	4.06	4.20	0.87	0.58	1.16
b cell line:RPMI1788	10427-106D4	173.39	143.20	91.15	5.50	2.23	0.89	0.30	0.59
basal cell carcinoma cell line:TE 354.T	10702-109G9	44.39	33.57	16.09	1.39	0.83	0.00	0.55	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	159.56	173.06	65.59	3.77	2.08	4.07	1.19	0.69
bile duct carcinoma cell line:TFK-1	10496-107C1	171.56	112.98	58.92	1.34	1.84	4.35	2.01	1.34
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	218.10	242.15	44.18	2.80	6.71	1.68	2.24	0.56
bladder, adult, pool1	10011-101C2	171.76	112.66	71.27	2.93	0.54	0.43	0.76	1.96
blood, adult, pool1	10053-101G8	68.65	26.58	22.15	4.43	6.64	2.21	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	73.65	46.24	21.41	1.71	0.86	0.00	0.00	0.86
bone marrow, adult	10192-103E3	116.74	101.22	42.51	7.42	0.67	0.67	1.35	2.02
brain, adult, donor1	10084-102B3	70.73	75.86	38.95	3.08	0.00	0.00	0.00	1.03
brain, adult, pool1	10012-101C3	149.33	114.70	65.48	4.79	0.45	0.33	0.67	1.56
brain, fetal, pool1	10085-102B4	93.50	80.14	74.80	5.34	0.00	0.00	2.67	0.00
breast carcinoma cell line:MCF7	10482-107A5	154.61	142.39	45.92	2.97	1.32	0.33	2.97	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	239.78	231.67	111.34	7.36	1.12	0.12	1.37	0.25
breast, adult, donor1	10080-102A8	75.76	106.07	27.78	2.53	0.00	0.63	1.26	1.26
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	140.00	197.93	66.82	9.02	4.70	3.68	2.29	1.02
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	156.16	160.49	87.20	8.35	3.09	1.55	1.55	0.93
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	50.19	144.81	42.13	14.27	6.22	1.84	1.84	0.46
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	141.38	101.68	60.28	4.60	3.39	2.42	2.18	0.73
carcinoid cell line:NCI-H1770	10703-109H1	192.77	128.36	74.76	6.58	4.23	1.88	1.41	0.47
carcinoid cell line:NCI-H727	10735-110B6	207.60	156.41	77.44	4.81	0.33	0.22	2.19	0.98
carcinoid cell line:SK-PN-DW	10719-109I8	128.34	79.86	47.22	4.12	7.92	0.95	1.90	1.58
carcinosarcoma cell line:JHUCS-1	10642-109A3	383.83	253.67	139.74	9.05	3.19	3.19	5.86	1.60
caudate nucleus - adult, donor10196	10177-103C6	146.22	201.48	77.14	12.66	0.00	2.30	2.30	4.61
caudate nucleus, adult, donor10252	10164-103B2	190.92	156.78	78.48	7.86	1.51	0.50	1.51	1.51
caudate nucleus, adult, donor10258	10379-105H1	89.40	113.09	50.43	2.29	1.53	0.76	0.76	1.53
caudate nucleus, newborn, donor10223	10354-105E3	110.97	143.93	56.40	5.86	2.20	1.46	1.46	0.00
cerebellum - adult, donor10196	10173-103C2	533.13	224.32	233.06	23.31	0.00	2.91	2.91	8.74
cerebellum, adult, donor10252	10166-103B4	526.73	213.72	197.92	8.11	1.92	0.64	3.63	7.47
cerebellum, adult, pool1	10083-102B2	134.18	52.78	54.50	3.45	0.69	0.00	0.69	1.38
cerebellum, newborn, donor10223	10357-105E6	247.43	207.57	131.19	10.79	0.00	0.83	0.83	1.66
cerebral meninges, adult	10188-103D8	113.97	96.57	51.69	5.80	1.01	0.25	2.02	1.26
cerebrospinal fluid, donor2	10294-104G6	59.93	92.09	24.12	1.46	0.00	0.73	2.19	0.00
cervical cancer cell line:D98-AH2	10552-107I3	208.34	90.58	58.38	2.44	1.87	5.61	0.43	0.43
cervical cancer cell line:ME-180	10553-107I4	153.78	99.26	52.86	2.32	2.32	0.50	0.17	0.50
cervix, adult, pool1	10013-101C4	202.53	134.60	97.43	5.25	0.84	0.94	1.26	2.52
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	130.28	75.24	35.39	1.25	1.25	0.42	0.84	0.42
chondrosarcoma cell line:SW 1353	10700-109G7	78.38	58.78	27.43	2.61	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	322.87	218.10	67.98	5.10	2.36	1.24	0.99	2.86
choriocarcinoma cell line:SCH	10785-110H2	101.77	147.98	40.78	3.20	2.34	0.49	2.22	0.49
choriocarcinoma cell line:T3M-3	10618-108G6	153.93	291.02	71.63	6.40	0.71	1.90	0.71	0.00
chorionic membrane cells, donor1	12238-129G6	76.93	67.24	23.08	1.14	0.57	0.28	1.99	0.00
chorionic membrane cells, donor2	12239-129G7	98.83	104.10	36.59	2.19	0.70	0.20	0.40	1.19
chorionic membrane cells, donor3	12240-129G8	72.53	89.57	38.46	3.85	1.10	0.55	1.65	1.65
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	161.57	161.57	61.60	13.13	6.06	3.03	3.03	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	228.79	206.89	90.29	3.84	7.30	4.03	2.11	0.77
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	230.19	195.35	119.32	6.34	1.69	3.80	2.32	0.84
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	334.10	286.33	162.30	12.58	0.77	3.34	2.57	1.80
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	400.55	325.33	209.71	10.64	0.73	3.87	1.45	1.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	402.13	337.99	193.63	15.47	0.20	5.90	2.24	1.63
chronic myelogenous leukemia cell line:K562	10454-106G4	342.45	274.14	132.21	7.95	5.01	13.54	2.06	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	486.85	231.96	189.47	8.08	1.04	8.60	3.13	1.04
clear cell carcinoma cell line:JHOC-5	10638-108I8	122.75	115.89	58.06	6.17	2.97	0.23	2.51	0.91
clear cell carcinoma cell line:TEN	10636-108I6	83.80	64.20	35.40	1.21	1.21	2.26	0.69	0.52
colon carcinoma cell line:CACO-2	10513-107D9	151.38	239.97	64.80	5.13	2.75	4.76	1.10	0.18
colon carcinoma cell line:COLO-320	10420-106C6	259.98	257.70	135.69	13.30	2.28	4.18	2.66	0.76
colon, adult, donor1	10082-102B1	105.91	80.92	38.08	2.38	0.00	0.00	0.00	1.19
colon, adult, pool1	10014-101C5	170.61	129.61	65.33	3.41	0.82	0.35	0.47	2.12
colon, fetal, donor1	10070-101I7	95.17	88.99	55.62	3.09	1.24	1.24	1.24	3.09
common myeloid progenitor CMP, donor1	12130-128D6	605.02	348.35	183.34	4.58	0.00	4.58	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	125.18	25.04	25.04	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	202.27	286.40	101.13	5.95	5.10	4.67	0.85	1.27
cord blood derived cell line:COBL-a 24h infection	10453-106G3	219.61	268.66	113.20	8.45	2.57	3.32	1.06	1.21
cord blood derived cell line:COBL-a untreated	10449-106F8	231.12	276.10	112.24	6.06	5.92	4.65	1.55	1.13
corpus callosum, adult, pool1	10042-101F6	211.17	232.84	92.54	6.52	0.66	1.11	1.44	0.22
cruciate ligament, donor2	10295-104G7	102.93	130.49	53.49	7.29	0.00	0.81	2.43	0.00
diaphragm, fetal, donor1	10069-101I6	85.87	95.50	23.27	1.61	0.00	0.00	1.61	2.41
diencephalon, adult	10193-103E4	100.32	131.03	52.08	4.08	1.68	0.24	2.16	3.12
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	290.23	220.20	144.43	5.74	6.43	4.13	12.63	3.21
ductal cell carcinoma cell line:KLM-1	10438-106E6	178.23	243.10	90.52	9.23	1.03	4.10	1.54	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	142.51	201.97	47.90	6.98	3.85	1.69	0.24	0.48
ductus deferens, adult	10196-103E7	145.02	125.58	80.73	2.49	2.49	0.50	2.49	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	133.94	95.06	56.17	0.00	0.00	1.44	1.44	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	165.52	219.22	91.96	6.62	1.47	0.00	6.62	2.94
dura mater, adult, donor1	10041-101F5	179.30	59.96	73.25	1.49	0.33	1.16	0.33	0.58
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	214.74	266.71	49.08	8.44	2.00	11.55	1.78	2.66
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	310.37	322.70	74.23	11.61	6.73	15.05	1.15	1.15
embryonic pancreas cell line:1B2C6	10604-108F1	139.35	149.84	71.53	4.93	0.62	0.62	0.62	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	70.83	65.39	39.05	1.21	1.51	2.72	0.91	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	129.98	127.20	63.91	4.32	0.00	3.40	2.78	0.62
embryonic pancreas cell line:2C6	10603-108E9	161.56	177.32	78.81	3.94	0.00	3.94	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	197.10	207.49	88.83	5.03	1.01	9.05	1.68	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	135.56	99.50	70.14	2.72	0.36	1.63	1.27	1.63
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	64.81	108.07	35.70	1.29	0.48	0.16	2.41	0.16
epidermoid carcinoma cell line:A431	10426-106D3	183.97	124.72	68.70	5.34	1.56	1.00	1.00	0.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	175.87	90.74	62.03	3.41	1.21	0.77	0.77	0.55
epididymis, adult	10197-103E8	123.07	76.61	68.03	1.88	0.84	0.63	1.67	5.65
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	172.09	153.46	80.72	5.85	1.77	3.19	3.02	0.89
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	59.77	127.80	40.90	4.33	0.39	1.18	0.79	1.97
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	298.79	285.56	80.86	6.03	7.73	3.15	1.83	2.49
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	376.36	300.28	94.78	5.22	5.51	1.97	2.95	1.97
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	313.35	320.07	85.25	6.27	6.27	2.13	3.70	3.25
esophagus, adult, pool1	10015-101C6	136.23	115.10	51.60	3.61	1.06	0.42	0.74	2.76
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	248.34	244.34	144.40	4.76	0.88	5.64	0.63	0.75
eye - muscle inferior rectus, donor1	10272-104E2	106.24	65.19	50.71	0.00	0.00	0.00	2.41	7.24
eye - muscle lateral, donor2	10298-104H1	96.79	119.94	25.25	4.21	0.00	0.00	2.10	0.00
eye - muscle medial, donor2	10299-104H2	95.25	89.29	23.81	2.98	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	84.84	135.29	26.37	1.15	0.00	0.00	1.15	1.15
eye - vitreous humor, donor1	10268-104D7	71.41	135.54	48.09	10.20	1.46	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	138.56	108.81	50.85	5.34	0.76	1.02	2.80	1.02
fibrosarcoma cell line:HT-1080	10758-110E2	141.94	92.83	56.93	3.72	3.97	2.05	1.41	0.51
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	162.16	157.88	65.53	5.46	3.32	3.80	2.61	0.24
frontal lobe, adult, pool1	10040-101F4	178.45	136.98	79.09	4.32	0.09	0.38	0.28	0.47
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	312.56	177.75	93.68	4.20	5.10	1.20	3.90	3.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	118.96	51.20	40.96	3.11	0.64	1.83	0.09	0.37
gall bladder, adult	10198-103E9	146.79	117.34	58.19	3.14	0.24	0.72	0.97	1.69
gamma delta positive T cells, donor1	11937-126A2	187.36	47.24	101.47	0.00	0.54	1.61	0.54	1.61
gamma delta positive T cells, donor2	11938-126A3	187.12	44.07	66.85	1.49	2.61	2.24	1.49	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	88.50	89.98	29.36	2.53	1.27	1.90	1.48	1.27
gastric adenocarcinoma cell line:MKN45	10612-108F9	103.86	113.15	59.57	1.93	0.97	0.58	2.51	0.77
gastric cancer cell line:AZ521	10549-107H9	287.09	328.07	79.35	7.21	3.77	9.35	0.98	0.66
gastric cancer cell line:GSS	10560-108A2	82.37	161.99	95.18	2.75	0.00	0.92	0.92	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	302.71	192.59	67.39	5.94	1.83	1.37	4.57	2.51
giant cell carcinoma cell line:LU65	10487-107B1	77.79	73.43	32.24	2.07	1.38	2.87	0.57	0.23
giant cell carcinoma cell line:Lu99B	10433-106E1	171.31	219.18	111.97	11.76	2.38	5.04	0.98	0.56
glassy cell carcinoma cell line:HOKUG	10688-109F4	180.58	217.24	60.11	8.48	2.49	1.00	3.74	1.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	204.14	174.69	81.38	4.75	1.79	1.37	1.27	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	211.22	172.60	80.33	4.21	1.12	2.25	1.26	0.42
glioblastoma cell line:T98G	10485-107A8	174.83	100.22	59.16	4.19	1.66	1.77	1.43	1.10
glioma cell line:GI-1	10413-106B8	164.01	79.08	48.03	3.81	0.29	2.64	0.59	0.00
globus pallidus - adult, donor10196	10175-103C4	88.20	164.01	49.57	3.64	1.46	1.46	0.73	1.46
globus pallidus, adult, donor10252	10161-103A8	245.56	306.34	104.23	6.83	2.44	1.95	1.95	6.10
globus pallidus, adult, donor10258	10367-105F7	93.11	102.69	36.97	4.11	0.00	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	69.81	120.44	36.77	4.26	3.20	1.07	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	604.44	491.88	163.96	2.45	0.00	0.00	2.45	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	98.36	76.50	0.00	0.00	0.00	0.00	0.00	10.93
granulocyte macrophage progenitor, donor3	12139-128E6	62.72	36.59	20.91	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	89.60	85.44	30.40	2.56	1.60	0.00	1.28	0.64
hIPS +CCl2, biol_rep1	14383-156B9	170.79	255.73	54.18	6.89	3.67	11.48	3.67	0.92
hIPS +CCl2, biol_rep2	14384-156C1	143.58	327.86	70.88	13.26	4.12	11.89	2.29	0.46
hIPS +CCl2, biol_rep3	14385-156C2	121.73	267.94	70.21	11.59	0.64	13.53	2.58	0.00
hIPS, biol_rep1	14380-156B6	38.81	474.30	45.99	18.68	0.00	15.81	1.44	0.00
hIPS, biol_rep2	14381-156B7	87.11	264.06	52.13	4.80	0.69	10.97	1.37	0.00
hIPS, biol_rep3	14382-156B8	98.21	163.31	51.86	3.31	0.00	1.10	0.00	1.10
hairy cell leukemia cell line:Mo	10712-109I1	147.98	146.55	74.42	6.32	5.17	2.01	4.31	2.30
heart - mitral valve, adult	10205-103F7	138.72	156.06	57.10	4.48	0.90	0.90	0.90	2.09
heart - pulmonic valve, adult	10206-103F8	179.11	116.10	71.91	4.97	0.00	0.26	2.09	1.83
heart - tricuspid valve, adult	10207-103F9	228.14	436.30	95.75	9.99	2.50	1.67	0.83	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	98.15	68.36	33.47	1.02	1.22	0.61	2.45	1.43
heart, adult, diseased, donor1	10051-101G6	63.02	55.36	16.18	1.70	0.43	0.00	1.28	0.43
heart, adult, pool1	10016-101C7	113.84	107.17	37.49	1.15	0.92	0.00	0.69	0.69
heart, fetal, pool1	10046-101G1	241.30	189.96	88.72	5.65	0.41	0.41	0.62	0.51
hepatic mesenchymal tumor cell line:LI90	10778-110G4	64.48	45.66	26.22	0.62	1.54	0.00	0.62	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	464.97	386.48	147.46	14.27	1.19	8.32	1.19	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	435.24	333.81	104.75	8.73	4.20	12.49	3.31	2.32
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	429.06	352.47	101.59	9.10	3.40	11.29	3.64	2.91
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	474.14	377.53	115.40	9.09	4.04	13.44	3.44	1.92
hepatoma cell line:Li-7	10484-107A7	160.82	131.68	52.72	2.89	2.22	2.00	1.33	0.89
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	264.82	159.49	91.35	3.72	3.82	5.13	2.31	0.80
hippocampus - adult, donor10196	10169-103B7	105.99	123.02	50.16	4.73	4.73	0.00	0.95	0.00
hippocampus, adult, donor10252	10153-102I9	188.38	190.63	74.50	8.37	2.65	1.22	2.04	2.86
hippocampus, adult, donor10258	10374-105G5	59.75	138.43	66.73	7.97	0.50	0.50	3.49	0.50
hippocampus, newborn, donor10223	10363-105F3	77.19	109.62	40.53	3.88	0.70	1.41	1.41	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	247.80	272.21	71.41	10.38	14.65	23.19	6.71	3.05
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	172.40	228.75	64.60	10.21	7.85	11.58	2.95	0.98
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	188.39	244.50	79.47	6.60	6.86	13.71	2.79	2.79
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	137.02	141.53	71.05	10.71	6.20	2.26	0.56	2.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	166.80	150.28	86.50	19.11	4.13	1.29	7.49	5.68
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	172.34	195.12	96.80	11.39	4.18	1.90	0.76	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	178.97	126.71	94.30	11.97	2.34	2.92	2.63	3.21
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	178.81	137.23	84.66	12.28	1.94	3.23	3.66	3.66
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	160.16	128.88	85.50	9.59	2.92	2.09	2.50	2.09
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	237.50	112.48	80.51	5.68	1.66	3.32	1.89	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	253.77	120.70	88.07	6.43	4.50	4.82	2.25	3.05
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	232.96	107.06	83.49	4.04	0.67	5.39	1.35	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	169.63	250.22	65.72	7.51	6.42	10.33	3.60	1.56
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	137.56	248.59	62.89	7.86	8.84	14.74	9.33	6.88
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	167.57	234.77	73.31	5.24	10.47	25.31	2.62	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	174.68	189.19	94.31	12.98	3.82	0.57	1.72	2.67
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	139.98	178.79	87.21	10.90	5.67	0.87	0.00	2.18
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	144.43	128.94	54.47	7.00	6.00	1.00	1.00	1.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	95.33	118.88	68.57	15.64	2.07	0.38	2.45	2.83
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	90.94	128.23	72.75	12.28	1.36	1.36	0.91	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	103.68	99.92	63.59	12.22	4.07	0.63	4.07	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	145.83	81.00	60.91	3.92	4.25	2.45	1.63	1.80
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	124.83	81.29	55.74	6.39	4.94	0.87	1.16	1.74
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	141.09	78.02	59.49	5.38	5.38	1.20	1.79	1.49
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	181.79	227.97	70.39	7.94	6.84	11.27	4.80	2.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	151.20	229.37	61.62	6.85	5.99	7.42	3.42	1.43
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	230.70	260.91	70.23	13.07	13.47	16.74	3.27	2.04
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	149.99	169.70	80.63	14.08	2.82	2.82	4.58	1.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	138.42	167.24	69.05	10.45	3.80	0.95	2.85	1.58
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	160.39	170.38	77.17	14.53	2.72	1.21	1.21	0.61
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	132.38	142.73	58.43	8.27	0.52	2.07	0.52	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	109.59	138.81	59.77	11.29	2.66	1.99	0.00	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	162.13	122.62	80.81	9.75	1.03	2.31	0.26	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	150.83	92.80	60.59	6.39	1.28	2.30	2.81	2.05
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	156.75	130.24	81.78	6.06	1.51	2.27	1.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	126.36	71.92	52.76	3.70	2.02	2.35	0.34	1.68
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	171.95	240.54	61.83	8.69	5.07	9.18	3.62	2.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	213.03	207.23	82.45	7.58	10.70	15.15	3.57	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	200.98	219.51	73.66	9.27	9.76	9.76	2.44	2.44
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	147.61	209.04	79.15	16.81	3.06	1.22	2.14	1.83
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	598.60	582.33	182.18	65.06	22.77	9.76	29.28	13.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	171.43	196.91	85.05	15.22	6.29	1.65	3.97	3.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	152.70	192.10	94.14	14.23	4.38	1.64	2.19	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	145.48	136.79	89.02	11.58	2.17	1.09	1.09	1.81
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	144.84	126.69	85.41	12.10	2.85	1.07	0.36	1.42
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	130.08	118.14	53.70	4.77	1.19	2.39	2.39	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	225.21	120.93	95.34	5.01	0.95	2.57	1.35	2.03
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	136.31	73.28	51.72	7.00	4.85	2.42	1.62	0.27
immature langerhans cells, donor1	11904-125F5	95.41	104.12	41.89	5.57	0.48	2.91	1.70	0.24
immature langerhans cells, donor2	11905-125F6	58.62	188.53	30.10	5.54	1.58	3.17	0.79	0.79
insula, adult, pool1	10039-101F3	191.73	141.95	91.61	4.83	0.38	0.28	0.28	0.76
keratoacanthoma cell line:HKA-1	10791-110H8	85.19	76.08	33.82	2.60	5.53	0.33	1.30	0.00
kidney, adult, pool1	10017-101C8	149.19	148.49	66.48	3.10	0.40	0.70	1.10	1.50
kidney, fetal, pool1	10045-101F9	192.19	192.19	85.87	6.01	0.78	0.64	0.50	0.42
large cell lung carcinoma cell line:IA-LM	10509-107D5	225.53	182.78	71.44	4.54	1.42	3.83	0.14	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	97.88	84.33	45.21	3.46	1.66	0.83	0.83	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	113.04	105.33	38.53	5.32	2.20	0.55	0.55	0.18
left atrium, adult, donor1	10079-102A7	48.49	32.69	24.52	2.18	1.63	0.00	1.63	3.81
left ventricle, adult, donor1	10078-102A6	48.54	43.49	25.79	1.52	0.00	0.00	2.02	3.03
leiomyoblastoma cell line:G-402	10721-110A1	240.50	189.89	98.77	4.65	1.09	1.92	0.82	0.00
leiomyoma cell line:10964C	10569-108B2	32.33	51.73	13.29	2.16	1.80	0.00	0.72	0.00
leiomyoma cell line:15242A	10570-108B3	28.26	37.50	10.33	1.09	2.72	0.00	0.00	0.00
leiomyoma cell line:15425	10571-108B4	46.62	67.02	19.67	1.70	2.67	0.97	0.97	0.49
leiomyosarcoma cell line:Hs 5.T	10722-110A2	38.10	50.79	6.35	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	129.65	62.73	27.18	5.23	1.05	1.05	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	278.50	112.86	94.09	6.26	2.60	2.36	2.36	1.06
liposarcoma cell line:KMLS-1	10782-110G8	77.01	73.73	34.05	4.06	0.78	1.56	0.94	0.62
liposarcoma cell line:SW 872	10726-110A6	151.81	91.26	40.45	3.29	1.22	0.73	1.34	0.73
liver, adult, pool1	10018-101C9	112.79	116.20	41.65	1.62	0.32	2.11	0.65	7.29
liver, fetal, pool1	10086-102B5	43.27	76.20	27.28	1.88	0.94	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	139.26	186.36	65.77	7.15	0.73	0.73	1.31	0.58
locus coeruleus, adult, donor10252	10165-103B3	133.80	171.82	56.84	4.43	2.77	1.48	2.03	2.95
locus coeruleus, adult, donor10258	10375-105G6	62.92	60.94	27.09	3.10	0.00	0.28	2.26	1.13
locus coeruleus, newborn, donor10223	10362-105F2	105.58	171.19	51.32	6.31	1.68	0.84	0.42	2.52
lung adenocarcinoma cell line:A549	10499-107C4	77.09	138.12	34.05	2.63	0.83	2.21	0.14	0.42
lung adenocarcinoma cell line:PC-14	10408-106B3	242.67	183.38	88.24	9.65	0.00	0.69	0.69	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	150.80	129.71	57.08	4.48	0.26	1.98	1.98	0.53
lung, adult, pool1	10019-101D1	149.19	128.17	62.73	2.13	0.47	0.12	1.30	3.07
lung, fetal, donor1	10068-101I5	238.03	601.35	148.70	9.13	0.86	2.28	0.86	2.57
lung, right lower lobe, adult, donor1	10075-102A3	107.22	94.39	52.24	3.21	0.92	0.46	2.29	11.00
lymph node, adult, donor1	10077-102A5	124.97	48.76	62.48	1.42	0.47	0.95	1.89	4.26
lymphangiectasia cell line:DS-1	10727-110A7	198.36	96.66	87.67	3.51	2.19	1.53	0.22	0.88
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	170.70	112.29	79.69	5.43	2.87	5.89	1.51	0.60
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	262.49	149.51	60.31	4.25	4.25	0.00	0.85	0.85
mature adipocyte, donor1	12231-129F8	91.02	110.11	27.53	2.66	0.44	0.00	0.00	0.44
mature adipocyte, donor2	12232-129F9	77.20	105.84	23.45	1.25	0.62	0.21	0.00	0.21
mature adipocyte, donor3	12233-129G1	69.70	95.54	19.20	0.71	0.95	1.19	0.00	0.24
mature adipocyte, donor4	12234-129G2	95.81	79.75	21.06	0.53	0.79	0.53	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	324.75	194.66	126.99	5.96	1.67	7.15	1.19	0.95
medial frontal gyrus - adult, donor10196	10170-103B8	131.98	135.36	68.81	5.64	1.13	1.13	2.26	2.26
medial frontal gyrus, adult, donor10252	10150-102I6	196.96	165.33	84.05	4.60	1.29	0.74	1.84	2.57
medial frontal gyrus, adult, donor10258	10368-105F8	59.41	62.90	31.45	2.86	1.91	0.32	1.59	0.64
medial frontal gyrus, newborn, donor10223	10352-105E1	111.31	119.84	62.27	6.82	2.13	1.71	2.56	1.28
medial temporal gyrus - adult, donor10196	10183-103D3	148.50	157.95	76.95	10.63	0.34	0.34	5.57	7.93
medial temporal gyrus, adult, donor10252	10156-103A3	193.97	189.94	84.68	4.88	2.12	0.85	2.55	1.91
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	30.82	154.10	26.97	5.78	0.00	0.00	5.78	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	545.44	301.43	200.95	14.35	14.35	0.00	0.00	71.77
medial temporal gyrus, newborn, donor10223	10353-105E2	98.71	116.65	53.48	4.31	0.36	2.51	0.72	0.72
medulla oblongata - adult, donor10196	10174-103C3	87.61	121.36	46.08	3.89	1.30	1.95	2.60	0.00
medulla oblongata, adult, donor10252	10155-103A2	186.23	200.78	71.83	5.88	2.01	1.24	1.39	4.64
medulla oblongata, adult, pool1	10038-101F2	153.95	152.32	68.24	3.92	0.16	0.73	0.16	0.41
medulla oblongata, newborn, donor10223	10361-105F1	76.38	133.66	45.83	6.25	2.78	1.39	1.39	0.69
medulloblastoma cell line:D283 Med	10838-111E1	609.77	514.34	355.59	23.69	3.76	7.53	6.20	4.21
medulloblastoma cell line:ONS-76	10759-110E3	291.50	169.23	98.92	4.77	1.22	4.65	1.71	0.73
melanoma cell line:COLO 679	10514-107E1	173.65	104.93	64.11	2.73	1.58	2.44	0.00	1.29
melanoma cell line:G-361	10465-106H6	120.53	75.47	40.45	1.90	1.63	1.36	1.09	2.17
meningioma cell line:HKBMM	10691-109F7	59.70	65.67	18.81	2.53	3.08	0.18	1.45	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	722.55	323.38	185.04	17.62	4.41	2.64	7.05	8.81
merkel cell carcinoma cell line:MS-1	10844-111E7	331.55	170.05	128.32	9.85	5.44	1.81	2.33	1.04
mesenchymal precursor cell - adipose, donor1	11747-123G1	59.69	85.77	39.59	3.22	1.38	1.07	0.92	0.31
mesenchymal precursor cell - adipose, donor2	11748-123G2	49.81	61.62	26.90	2.36	1.64	1.64	1.09	0.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	31.47	88.62	32.30	4.97	2.48	1.66	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	39.61	64.48	18.96	1.12	1.83	0.14	0.42	0.42
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	41.79	50.26	22.53	1.73	1.73	0.58	0.39	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	64.55	77.04	26.37	3.47	0.00	0.69	0.69	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	26.09	54.41	12.87	1.03	0.51	0.34	0.17	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	47.50	75.34	25.88	2.07	1.27	0.46	0.35	0.35
mesenchymal precursor cell - cardiac, donor3	11754-123G8	49.21	66.98	28.25	2.65	1.06	0.40	0.66	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	60.50	71.71	30.79	2.16	1.35	0.00	0.41	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	47.09	98.02	32.15	2.85	1.28	0.71	1.28	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	42.82	55.99	26.35	1.98	0.99	0.00	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	61.16	69.74	34.18	2.08	1.52	0.69	0.69	0.42
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	53.76	78.54	44.33	1.75	1.40	0.00	2.44	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	35.52	39.61	17.76	1.22	0.41	0.00	0.20	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	50.32	54.64	21.21	1.08	0.72	0.36	0.00	1.08
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	30.31	41.48	18.21	1.97	1.03	0.10	0.41	0.31
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	33.74	50.39	11.17	0.68	0.46	0.00	0.68	0.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	57.06	120.41	51.61	2.94	1.68	2.10	0.84	0.84
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	52.00	60.97	31.68	2.24	0.75	0.30	0.45	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	44.29	68.80	22.58	1.58	1.05	0.18	0.35	0.26
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	49.33	51.17	18.41	1.84	0.00	0.00	0.00	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	43.21	59.23	27.47	2.58	0.86	0.00	0.29	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	126.73	125.88	45.05	5.05	5.47	0.84	4.21	0.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	42.47	69.41	32.42	3.65	0.91	0.00	0.91	0.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	57.81	62.92	27.62	2.56	1.02	0.51	2.05	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	61.25	71.46	31.15	2.88	2.62	0.26	0.79	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	67.16	68.40	28.34	4.01	0.92	0.62	0.62	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	49.66	60.25	27.54	2.82	1.41	0.24	1.18	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	59.91	64.98	32.83	4.06	2.37	0.00	0.68	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	49.91	67.59	25.54	4.32	1.18	0.39	0.39	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	58.39	63.02	35.68	3.24	2.32	0.00	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	96.61	96.61	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	66.05	72.97	30.86	4.04	0.87	0.00	0.58	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	64.25	72.06	27.66	2.68	1.34	0.22	0.45	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	56.96	72.35	36.05	1.44	1.20	0.96	0.24	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	75.53	80.67	40.33	3.67	0.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	55.72	51.02	27.19	1.01	3.36	0.34	0.34	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	50.35	62.63	24.15	2.46	2.05	0.41	1.64	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	63.15	67.87	31.79	3.01	3.01	0.00	0.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	38.28	54.69	21.88	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	67.14	56.81	25.82	0.00	0.00	0.00	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	47.74	54.89	17.54	1.95	1.30	0.32	0.00	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	53.83	64.02	23.28	4.36	4.36	0.00	1.45	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	41.58	51.71	16.53	1.07	2.67	0.00	0.53	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	35.16	58.06	18.81	1.64	4.91	0.00	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	43.54	51.31	25.27	2.33	2.33	0.00	0.78	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	39.88	44.07	12.59	2.10	2.10	0.00	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	39.74	44.71	20.86	0.99	1.99	0.99	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	19.07	38.14	28.60	0.00	0.00	0.00	0.00	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	37.36	56.33	19.57	1.19	1.19	0.59	0.59	1.19
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	32.90	53.61	25.59	1.22	2.44	0.00	0.00	2.44
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	81.16	54.10	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	34.84	57.64	19.63	4.43	1.90	0.63	1.27	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	30.01	42.77	21.04	0.34	1.72	0.00	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	17.19	30.09	12.90	0.00	0.00	0.00	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	7.98	11.98	11.98	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	41.33	51.66	27.55	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	42.38	44.41	19.97	0.00	1.22	0.00	2.85	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	45.28	37.34	15.89	0.79	2.38	0.00	3.18	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	46.57	46.57	14.15	2.95	1.77	0.59	1.18	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	50.81	44.89	20.57	0.62	2.18	0.00	1.56	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	53.47	57.48	8.02	1.34	0.00	0.00	2.67	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	48.49	46.12	24.84	3.55	0.00	0.00	3.55	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	66.77	69.34	33.38	2.57	2.57	0.00	10.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	52.32	58.51	25.47	3.44	2.07	1.38	4.13	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	53.44	47.01	12.86	0.99	0.49	0.00	2.47	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	37.01	43.74	12.34	0.00	0.00	0.00	4.49	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	46.43	52.16	14.63	1.27	1.27	0.00	3.18	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	30.22	52.79	14.10	2.01	1.61	0.40	1.21	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	21.81	32.71	8.72	2.18	4.36	0.00	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	25.34	30.41	6.34	0.00	3.80	0.00	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	33.99	57.65	10.32	1.21	0.61	0.00	0.00	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	22.59	27.11	9.04	0.00	9.04	0.00	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	34.59	37.07	11.53	0.82	3.29	0.00	2.47	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	36.71	41.27	18.45	1.39	1.19	0.60	0.20	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	38.61	45.10	17.52	0.32	2.60	0.65	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	36.67	46.86	11.20	1.02	2.04	0.00	2.04	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	70.41	64.22	19.34	1.55	0.00	0.77	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	102.77	79.14	48.67	2.60	1.89	0.71	0.47	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	140.16	182.10	44.48	0.70	0.70	2.55	0.93	0.70
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	128.21	76.92	42.74	0.00	0.00	4.27	12.82	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	80.15	37.81	16.13	0.72	1.13	0.72	1.64	1.44
mesothelioma cell line:Mero-25	10850-111F4	73.53	151.15	31.55	2.50	1.82	0.91	1.36	0.68
mesothelioma cell line:Mero-41	10851-111F5	111.97	220.27	69.92	4.40	1.96	1.96	3.91	2.44
mesothelioma cell line:Mero-48a	10852-111F6	103.19	118.47	44.51	4.21	3.76	1.33	3.76	1.99
mesothelioma cell line:Mero-82	10853-111F7	133.24	173.45	50.98	5.78	5.26	0.53	7.36	4.73
mesothelioma cell line:Mero-83	10854-111F8	118.30	123.75	40.51	2.04	2.21	2.72	3.40	1.02
mesothelioma cell line:Mero-84	10855-111F9	8.09	302.57	11.12	6.32	3.29	0.25	0.51	0.25
mesothelioma cell line:Mero-95	10856-111G1	119.88	141.00	54.66	4.55	3.11	2.48	1.86	0.83
mesothelioma cell line:NCI-H2052	10847-111F1	99.22	159.02	42.57	4.31	2.65	1.66	4.14	1.66
mesothelioma cell line:NCI-H226	10846-111E9	131.22	120.36	37.47	3.44	3.80	5.97	2.17	0.90
mesothelioma cell line:NCI-H2452	10848-111F2	83.87	129.65	41.85	3.07	2.56	1.02	0.85	0.68
mesothelioma cell line:NCI-H28	10845-111E8	194.92	204.59	87.54	8.65	5.60	4.33	3.56	2.04
mesothelioma cell line:No36	10857-111G2	119.72	156.25	54.48	4.89	3.26	0.65	1.63	1.63
mesothelioma cell line:ONE58	10858-111G3	90.77	101.88	40.64	3.25	1.35	1.35	1.90	0.27
migratory langerhans cells, donor1	11901-125F2	87.52	89.44	66.41	2.69	0.19	0.19	1.15	0.38
migratory langerhans cells, donor2	11902-125F3	73.03	70.09	52.39	2.08	0.61	0.24	0.37	0.37
migratory langerhans cells, donor3	11903-125F4	89.74	68.38	54.38	1.97	0.18	0.18	0.54	0.36
mixed mullerian tumor cell line:HTMMT	10689-109F5	99.25	41.79	22.85	1.63	2.29	0.33	2.61	1.96
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	78.63	29.04	30.94	3.18	1.70	1.70	1.06	0.64
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	233.12	136.60	60.81	5.76	2.53	0.69	1.61	0.69
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	111.70	108.66	52.14	1.90	2.66	0.76	0.95	1.14
myelodysplastic syndrome cell line:SKM-1	10772-110F7	354.62	191.63	108.29	4.44	3.88	1.66	0.92	1.48
myeloma cell line:PCM6	10474-106I6	126.70	55.54	59.70	1.58	1.78	1.58	1.19	0.59
myxofibrosarcoma cell line:MFH-ino	10600-108E6	184.65	242.99	71.53	10.15	0.51	1.52	3.55	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	120.23	56.29	48.64	1.77	0.98	0.39	0.98	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	40.34	91.03	28.08	2.45	0.67	1.34	0.22	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	49.86	85.82	22.14	2.43	0.59	1.40	0.44	0.37
nasal epithelial cells, donor2	12227-129F4	157.32	213.62	55.20	3.86	2.21	1.66	0.55	1.10
neuroblastoma cell line:CHP-134	10508-107D4	487.96	208.44	211.66	6.44	2.07	15.18	1.84	0.23
neuroblastoma cell line:NB-1	10539-107G8	438.15	262.85	155.47	9.35	4.12	3.18	1.12	1.12
neuroblastoma cell line:NBsusSR	10607-108F4	237.46	142.77	104.81	3.80	1.69	3.59	3.80	1.27
neuroblastoma cell line:NH-12	10555-107I6	350.34	239.65	187.10	12.49	2.80	8.39	5.40	1.12
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	378.85	210.42	145.89	7.59	5.46	0.95	7.35	2.37
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	219.83	168.20	85.68	7.92	3.01	2.06	2.06	1.90
neuroectodermal tumor cell line:TASK1	10774-110F9	185.36	107.27	64.00	3.22	5.84	4.63	2.42	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	322.97	171.02	97.91	6.99	0.00	3.81	1.27	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	80.12	73.20	28.21	3.46	1.06	1.06	1.33	0.27
neutrophil PMN, donor1	12133-128D9	178.50	208.25	74.37	14.87	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	13.28	26.56	79.68	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	75.77	37.88	37.88	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	567.74	372.91	225.44	11.67	3.04	1.01	2.20	2.03
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	188.92	188.92	74.45	12.81	1.60	2.40	0.80	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	59.31	54.82	24.05	4.49	3.53	0.96	1.92	0.96
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	75.94	73.05	27.59	0.26	2.63	0.00	0.26	0.53
nucleus accumbens, adult, pool1	10037-101F1	180.92	150.45	82.12	4.03	1.31	0.47	0.37	0.19
occipital cortex - adult, donor10196	10172-103C1	179.25	197.80	72.11	16.48	2.06	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	206.37	209.05	85.07	6.98	2.68	1.07	2.95	2.68
occipital cortex, newborn, donor10223	10355-105E4	124.83	148.85	66.97	6.55	0.73	0.36	0.73	0.36
occipital lobe, adult, donor1	10076-102A4	91.84	102.86	56.42	6.30	1.05	0.26	1.57	3.67
occipital lobe, fetal, donor1	10073-102A1	175.07	159.63	93.97	7.29	1.72	1.72	2.15	3.86
occipital pole, adult, pool1	10036-101E9	113.14	97.45	62.99	3.07	0.39	0.32	0.47	0.00
olfactory region, adult	10195-103E6	131.44	142.33	70.12	8.60	0.96	0.76	3.63	3.44
optic nerve, donor1	10277-104E7	178.09	158.08	54.03	2.00	2.00	0.00	0.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	128.26	139.99	52.74	3.99	1.37	2.16	0.34	0.46
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	134.78	159.09	60.86	4.40	1.24	5.08	0.55	0.27
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	140.37	112.26	51.64	3.73	1.86	1.02	2.88	1.52
oral squamous cell carcinoma cell line:SAS	10544-107H4	110.20	181.46	57.87	6.93	1.73	0.58	3.58	0.92
osteoclastoma cell line:Hs 706.T	10704-109H2	93.78	63.79	38.51	2.06	1.18	0.88	0.29	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	574.62	212.09	143.89	8.41	0.00	2.80	0.00	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	199.97	134.66	58.95	3.18	1.70	2.33	1.06	0.42
ovary, adult, pool1	10020-101D2	207.63	187.54	93.99	6.38	0.61	1.66	0.96	3.49
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	92.94	72.41	28.60	2.20	0.92	0.73	2.20	0.55
pancreas, adult, donor1	10049-101G4	118.52	92.18	63.96	5.64	0.00	0.94	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	172.47	155.98	44.45	2.80	5.59	1.40	1.40	1.12
papillary adenocarcinoma cell line:8505C	10437-106E5	119.93	55.02	31.52	2.73	1.53	1.19	3.75	1.19
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	130.64	141.57	55.30	2.98	1.32	0.99	0.50	0.17
paracentral gyrus, adult, pool1	10035-101E8	152.20	132.71	76.51	4.03	0.82	0.27	0.73	0.18
parietal cortex, adult, donor10258	10373-105G4	125.52	243.69	50.65	8.07	0.00	0.73	0.00	2.20
parietal lobe - adult, donor10196	10171-103B9	113.80	157.06	71.48	2.82	1.88	0.00	0.00	2.82
parietal lobe, adult, donor10252	10157-103A4	176.72	171.31	69.55	6.27	1.43	0.57	0.57	1.14
parietal lobe, adult, pool1	10034-101E7	147.34	130.15	72.08	3.79	0.35	0.44	0.62	0.44
parietal lobe, fetal, donor1	10072-101I9	198.82	158.08	101.83	7.76	2.91	3.88	5.82	9.70
parietal lobe, newborn, donor10223	10356-105E5	131.60	142.44	65.05	8.22	2.62	0.75	0.37	0.37
parotid gland, adult	10199-103F1	109.77	57.35	38.85	2.47	0.62	0.00	0.62	1.23
penis, adult	10200-103F2	129.98	87.55	61.77	3.22	3.76	1.07	2.15	2.15
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	187.24	136.11	89.44	5.02	1.30	6.14	2.97	1.67
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	103.01	127.05	42.98	3.50	1.60	0.87	2.19	1.17
pineal gland - adult, donor10196	10179-103C8	148.36	116.10	67.73	5.81	0.65	1.29	0.65	0.65
pineal gland, adult, donor10252	10160-103A7	201.35	171.74	97.72	9.48	0.59	1.78	2.37	1.78
pineal gland, adult, donor10258	10377-105G8	77.13	76.50	40.76	3.76	0.00	0.00	0.63	1.25
pituitary gland - adult, donor10196	10180-103C9	184.15	177.07	89.04	10.12	0.00	1.01	3.04	4.05
pituitary gland, adult, donor10252	10162-103A9	277.79	246.00	111.53	10.42	0.52	4.69	2.08	3.65
pituitary gland, adult, donor10258	10378-105G9	103.00	91.93	62.99	5.11	0.85	4.26	2.55	0.00
placenta, adult, pool1	10021-101D3	167.06	102.77	57.19	1.72	0.54	0.32	0.75	2.80
plasma cell leukemia cell line:ARH-77	10840-111E3	188.44	162.62	94.82	5.83	1.85	0.66	0.93	0.53
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	109.57	54.63	38.75	1.56	0.78	0.00	0.31	0.16
pons, adult, pool1	10033-101E6	147.61	131.42	65.24	5.59	0.34	0.69	0.86	0.26
postcentral gyrus, adult, pool1	10032-101E5	125.01	103.91	64.86	5.14	0.35	0.17	0.44	0.09
promyelocytes/myelocytes PMC, donor1	12132-128D8	269.79	299.07	125.48	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	143.21	93.64	44.06	0.00	5.51	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	46.94	23.47	46.94	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	106.19	187.03	48.07	3.64	1.31	1.89	1.60	0.87
prostate cancer cell line:PC-3	10439-106E7	218.35	192.57	81.13	4.36	1.63	2.36	2.36	1.27
prostate, adult, pool1	10022-101D4	164.79	135.49	71.19	3.45	0.54	0.73	0.45	4.08
putamen, adult, donor10196	10176-103C5	269.11	206.56	100.80	12.28	2.36	0.71	1.89	1.18
putamen, adult, donor10252	10152-102I8	94.11	139.21	43.14	0.00	1.96	0.00	5.88	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	66.66	265.55	36.06	8.74	0.00	3.28	2.19	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	118.87	109.21	55.09	6.04	0.72	0.00	1.69	1.21
putamen, newborn, donor10223	10365-105F5	122.94	136.44	47.23	6.00	2.25	1.50	0.75	3.00
rectal cancer cell line:TT1TKB	10469-106I1	201.91	268.82	86.99	3.20	0.87	3.20	2.04	0.00
rectum, fetal, donor1	10067-101I4	169.70	146.05	111.28	4.17	4.17	1.39	6.95	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	63.60	76.32	33.50	3.18	0.85	0.85	0.85	0.64
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	33.14	44.73	26.10	4.14	0.00	0.41	1.24	0.00
retina, adult, pool1	10030-101E3	200.59	103.87	65.60	3.98	0.40	1.19	0.50	0.30
retinoblastoma cell line:Y79	10475-106I7	332.81	158.22	103.92	6.24	4.94	7.53	2.34	1.56
rhabdomyosarcoma cell line:KYM-1	10787-110H4	220.57	181.59	77.70	6.39	3.20	1.84	3.07	1.11
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	565.49	487.32	251.67	14.06	3.09	5.91	3.94	1.97
sacrococcigeal teratoma cell line:HTST	10695-109G2	118.98	141.72	31.83	3.79	0.76	0.76	1.52	1.52
salivary acinar cells, donor1	11771-123I7	84.81	84.00	50.34	3.56	0.65	0.65	0.65	0.49
salivary acinar cells, donor2	11772-123I8	98.31	82.89	65.54	2.62	2.34	0.55	2.07	1.10
salivary acinar cells, donor3	11773-123I9	199.94	156.91	82.09	6.62	3.31	0.66	1.99	0.66
salivary gland, adult, pool1	10093-102C3	68.06	89.80	41.75	4.58	1.72	0.00	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	143.84	151.93	74.95	5.06	1.18	2.02	1.01	0.67
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	142.00	131.89	71.12	5.76	1.65	3.53	0.82	0.71
seminal vesicle, adult	10201-103F3	153.43	135.97	75.66	8.47	1.59	0.53	6.88	7.41
serous adenocarcinoma cell line:JHOS-2	10639-108I9	140.17	177.34	45.67	6.56	2.19	2.43	1.46	0.73
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	53.85	79.52	25.41	3.77	1.51	0.25	0.25	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	91.32	193.68	46.16	8.03	1.00	0.00	1.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	128.68	234.39	55.47	7.79	2.96	0.40	2.55	1.75
signet ring carcinoma cell line:Kato III	10436-106E4	114.84	70.96	40.45	1.88	1.55	1.44	0.33	0.44
signet ring carcinoma cell line:NUGC-4	10483-107A6	104.38	179.35	41.93	3.35	1.81	6.06	0.39	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	87.25	88.67	34.76	2.84	0.71	0.00	3.55	0.00
skeletal muscle, adult, pool1	10023-101D5	177.99	160.84	56.49	3.48	0.36	1.08	0.60	1.56
skeletal muscle, fetal, donor1	10066-101I3	110.55	81.41	38.19	6.03	2.01	1.01	2.01	4.02
skin, adult, donor1	10074-102A2	61.07	40.71	27.14	6.79	0.00	0.00	0.00	13.57
skin, fetal, donor1	10065-101I2	134.45	101.63	44.19	5.68	1.89	0.00	2.52	3.79
small cell cervical cancer cell line:HCSC-1	10800-110I8	174.10	143.08	72.04	7.34	3.34	3.67	2.00	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	452.95	85.42	88.26	6.93	2.21	3.78	5.36	4.10
small cell lung carcinoma cell line:DMS 144	10841-111E4	180.22	199.11	91.75	7.13	2.31	1.93	2.51	0.58
small cell lung carcinoma cell line:LK-2	10541-107H1	402.51	274.60	155.60	8.24	3.30	4.78	0.33	0.82
small cell lung carcinoma cell line:NCI-H82	10842-111E5	214.25	341.97	185.78	28.15	2.41	3.22	3.22	1.13
small cell lung carcinoma cell line:WA-hT	10562-108A4	232.74	126.61	94.79	6.76	3.27	1.31	1.53	0.65
small intestine, adult, pool1	10024-101D6	206.64	139.15	79.19	3.34	0.60	0.72	0.96	5.02
small intestine, fetal, donor1	10064-101I1	168.06	98.77	61.67	2.21	0.98	1.47	5.16	1.47
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	143.10	96.94	55.91	5.13	2.56	2.05	3.08	1.54
smooth muscle, adult, pool1	10048-101G3	157.14	116.30	58.41	2.84	1.03	0.00	1.29	1.03
somatostatinoma cell line:QGP-1	10781-110G7	237.47	91.40	84.16	3.75	0.54	0.54	1.07	1.34
spinal cord - adult, donor10196	10181-103D1	104.61	138.33	54.83	7.34	0.46	0.69	1.61	3.67
spinal cord, adult, donor10252	10159-103A6	123.01	219.61	73.73	7.49	0.79	1.97	1.58	6.31
spinal cord, adult, donor10258	10369-105F9	78.86	101.69	32.51	2.77	2.08	2.08	0.69	0.69
spinal cord, fetal, donor1	10056-101H2	119.53	115.87	61.59	9.76	1.22	0.61	0.00	0.61
spinal cord, newborn, donor10223	10359-105E8	99.19	147.41	41.33	5.97	0.46	1.84	0.92	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	103.50	76.47	31.81	2.54	0.60	0.00	0.75	0.15
spleen, adult, pool1	10025-101D7	203.64	113.99	86.01	1.87	0.88	0.99	1.10	5.18
spleen, fetal, pool1	10044-101F8	189.26	155.81	76.59	3.26	0.79	0.95	0.24	0.32
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	183.94	210.13	93.47	6.00	2.69	0.93	1.35	0.83
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	114.87	119.24	53.92	2.28	0.38	2.47	1.52	0.76
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	171.23	124.75	42.98	3.84	2.45	0.00	2.80	2.10
squamous cell carcinoma cell line:T3M-5	10616-108G4	98.51	89.91	29.32	2.74	0.39	0.78	1.17	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	147.11	71.36	57.18	3.26	1.35	4.16	1.35	0.45
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	94.04	176.22	69.89	9.74	0.00	5.08	0.42	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	144.27	109.15	49.08	1.69	0.00	0.42	1.27	0.42
stomach, fetal, donor1	10062-101H8	158.06	96.12	80.10	4.27	2.14	2.14	0.00	0.00
submaxillary gland, adult	10202-103F4	125.33	77.48	51.84	1.14	0.00	0.57	0.57	1.14
substantia nigra - adult, donor10196	10178-103C7	325.64	325.64	162.82	0.00	108.55	54.27	217.10	108.55
substantia nigra, adult, donor10252	10158-103A5	164.92	246.13	72.70	4.57	3.32	1.87	2.70	1.87
substantia nigra, adult, donor10258	10371-105G2	62.07	126.21	39.31	4.66	0.52	1.03	3.10	0.52
substantia nigra, newborn, donor10223	10358-105E7	65.71	114.47	36.74	2.83	0.71	2.12	0.71	2.12
synovial sarcoma cell line:HS-SY-II	10441-106E9	206.80	210.47	94.00	8.94	1.38	5.27	4.36	1.60
temporal lobe, adult, pool1	10031-101E4	123.17	101.05	61.46	3.98	0.42	0.42	0.25	0.34
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	191.60	123.93	86.90	9.26	2.14	1.42	4.27	1.42
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	194.28	174.06	102.85	4.83	0.88	3.08	3.96	1.76
tenocyte, donor1	11763-123H8	100.54	104.03	41.89	3.84	0.00	0.70	3.84	1.40
tenocyte, donor2	11765-123I1	63.71	63.71	22.13	1.91	0.76	0.38	2.67	0.76
tenocyte, donor3	11768-123I4	45.96	83.40	21.13	4.08	2.97	0.00	2.97	2.22
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	433.91	403.49	130.53	16.15	10.54	14.79	4.76	2.72
teratocarcinoma cell line:NCR-G1	10798-110I6	259.59	194.38	88.64	5.40	6.32	3.85	4.01	2.47
teratocarcinoma cell line:PA-1	10807-111A6	200.39	130.03	65.25	4.34	4.49	13.64	2.32	2.32
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	240.31	257.07	70.20	5.84	3.55	5.97	1.90	2.54
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	463.64	420.15	237.49	15.51	1.13	4.16	2.65	1.89
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	261.97	381.72	138.73	9.49	2.18	5.56	2.07	0.87
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	250.79	193.14	116.93	14.98	2.61	0.33	6.51	3.26
testis, adult, pool1	10026-101D8	155.37	110.38	71.62	9.77	0.43	4.51	0.43	18.68
testis, adult, pool2	10096-102C6	167.80	197.12	104.20	25.26	0.45	4.51	9.02	1.80
thalamus - adult, donor10196	10168-103B6	124.75	188.78	48.58	8.83	1.10	1.10	3.31	3.31
thalamus, adult, donor10252	10154-103A1	205.51	259.27	89.08	6.10	2.03	1.25	2.66	5.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	41.57	221.70	27.71	9.24	3.08	0.00	3.08	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	40.68	49.74	22.23	1.98	1.98	0.00	1.15	1.48
thalamus, newborn, donor10223	10366-105F6	53.50	84.57	27.04	4.03	1.73	2.30	0.00	0.58
throat, adult	10209-103G2	116.85	92.13	42.69	3.25	1.00	0.25	0.50	1.25
throat, fetal, donor1	10061-101H7	139.56	96.90	59.11	4.57	0.30	0.91	2.44	1.22
thymic carcinoma cell line:Ty-82	10803-111A2	232.91	263.52	101.35	10.14	3.97	17.89	1.59	0.40
thymus, adult, pool1	10027-101D9	503.04	220.60	152.50	6.96	0.70	1.99	1.69	14.02
thymus, fetal, pool1	10043-101F7	395.05	211.13	141.62	5.61	1.14	1.87	0.42	1.97
thyroid carcinoma cell line:KHM-5M	10776-110G2	99.72	85.76	40.42	2.26	2.79	0.40	0.66	1.06
thyroid carcinoma cell line:TCO-1	10783-110G9	153.52	101.28	66.07	6.29	1.54	1.82	1.96	0.98
thyroid, adult, pool1	10028-101E1	162.92	157.33	76.05	5.32	0.93	0.93	1.12	1.77
thyroid, fetal, donor1	10060-101H6	136.58	127.88	57.21	6.06	1.32	0.79	2.90	1.85
tongue epidermis (fungiform papillae), donor1	10288-104F9	166.30	61.59	58.51	0.00	0.00	6.16	3.08	0.00
tongue, adult	10203-103F5	117.68	89.08	32.79	3.26	0.23	0.47	0.93	3.72
tongue, fetal, donor1	10059-101H5	105.22	82.37	33.89	1.58	1.18	0.00	3.55	2.36
tonsil, adult, pool1	10047-101G2	212.77	114.80	100.88	2.91	0.20	0.90	0.60	0.20
trachea, adult, pool1	10029-101E2	153.94	139.63	69.53	3.35	0.41	1.47	0.57	4.91
trachea, fetal, donor1	10058-101H4	108.10	116.95	50.01	5.77	0.77	1.54	1.92	1.54
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	114.79	92.47	47.47	4.61	1.77	2.83	3.90	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	225.33	152.79	77.91	4.96	0.81	2.53	0.30	0.71
transitional-cell carcinoma cell line:JMSU1	10492-107B6	219.68	155.90	109.99	5.33	3.60	1.41	1.41	1.57
tridermal teratoma cell line:HGRT	10694-109G1	163.62	123.66	51.37	13.32	3.81	0.00	0.00	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	84.40	123.50	43.09	3.13	0.85	0.76	0.59	0.34
umbilical cord, fetal, donor1	10057-101H3	108.50	75.11	43.82	2.09	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	126.95	165.34	80.20	4.78	0.17	1.54	1.02	0.51
uterus, fetal, donor1	10055-101H1	137.71	119.28	65.53	7.68	1.02	1.02	1.02	1.54
vagina, adult	10204-103F6	165.43	301.13	68.50	2.58	0.65	1.29	0.00	1.29
vein, adult	10191-103E2	175.58	94.47	85.93	3.07	0.44	0.44	0.66	2.63
xeroderma pigentosum b cell line:XPL 17	10563-108A5	107.62	80.65	55.01	2.67	1.34	0.53	1.60	0.00